Disorders of optic nerve and visual pathways

H7_OPTNERVE

optic neuritis: Optic neuritis is inflammation of the optic nerve, the nerve that carries the visual signal from the eye to the brain.The conditionmay cause sudden, reduced vision in the affected eye(s). While the cause of optic neuritis is unknown, it has been associated with autoimmune diseases, infections, multiple sclerosis , drug toxicity and deficiency of vitamin B-12. Vision often returns to normal within 2-3 weeks without treatment. In some cases, corticosteroids are given to speed recovery. If known, the underlying cause should be treated.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H46-H48 Cause of death: ICD-10 — H46-H48 2 out of 7 registries used, show all original rules.	4146
4. Check minimum number of events None	4146
5. Include endpoints H7_OPTNEURITIS H7_OPTNEUROTH H7_RETROBULBNEURINOTH H7_OPTNERVPATHINOTH	4488
6. Filter based on genotype QC (FinnGen only)	4037

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	H7_OPTNERVE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	H7_OPTNEURITIS\|H7_OPTNEUROTH\|H7_RETROBULBNEURINOTH\|H7_OPTNERVPATHINOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H4[6-8]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H4[6-8]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Disorders of optic nerve and visual pathways based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4037	2640	1397
Unadjusted period prevalence (%)	0.83	0.94	0.64
Median age at first event (years)	46.22	41.38	55.37

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4216: Matched controls
42160

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

XCD10

NOMESCO Finland

Electrophysiological examination of eye

12.1

307.7

385

348

H47.2

ICD-10 Finland

Optic atrophy

+∞

307.7

683

109

Kela drug reimbursment

Multiple sclerosis

76.5

307.7

817

132

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

6.2

307.7

960

1910

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

6.7

307.7

694

1208

G35

ICD-10 Finland

Multiple sclerosis

66.5

307.7

995

195

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

72.5

307.7

682

112

164

Kela drug reimbursment

Fingolimod

79.5

307.7

240

L04AX07

ATC

dimethyl fumarate; oral

51.3

307.7

233

XCK00

NOMESCO Finland

Perimetry

15.6

307.7

1173

1014

H53.4

ICD-10 Finland

Visual field defects

14.6

307.7

383

286

L03AX13

ATC

glatiramer acetate; parenteral

77.3

307.7

315

N86

ICPC

Multiple sclerosis

59.7

307.7

351

H47.3

ICD-10 Finland

Other disorders of optic disc

1570.5

307.7

547

L04AA31

ATC

[U] teriflunomide

64.4

307.7

179

H46

ICD-10 Finland

Optic neuritis

11506.0

307.7

1521

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

81.6

307.7

736

109

L03AB08

ATC

interferon beta-1b; parenteral

94.9

307.7

173

L04AA27

ATC

[U] fingolimod

86.9

307.7

175

XCW99

NOMESCO Finland

Other investigative procedure of eye

4.9

307.7

908

2245

G93.2

ICD-10 Finland

Benign intracranial hypertension

113.7

307.7

226

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

35.4

307.7

303

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

11.5

307.7

541

534

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

31.8

307.7

226

L03AB07

ATC

interferon beta-1a; parenteral

77.5

307.7

413

H47.1

ICD-10 Finland

Papilloedema, unspecified

2692.8

307.7

907

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

10.6

307.7

523

558

353

Kela drug reimbursment

Cladribine and fingolimod

83.9

307.7

215

TAB00

NOMESCO Finland

Lumbar puncture

10.1

307.7

764

900

Z01.0

ICD-10 Finland

Examination of eyes and vision

5.0

307.7

1596

4544

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

4376.6

307.7

749

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

8.0

307.7

1193

1973

CS494

NOMESCO Finland

Other visual field testing

10.1

302.9

355

379

XCK10

NOMESCO Finland

Photography of fundus of eye

4.8

290.3

752

1826

N04BB01

ATC

amantadine; oral

12.9

257.7

253

207

N07XX09

ATC

[U] dimethyl fumarate

54.8

252.0

143

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.1

251.2

799

2257

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

9.8

248.7

297

324

H53.1

ICD-10 Finland

Subjective visual disturbances

4.6

237.9

630

1545

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

18.5

237.5

191

108

S01EC01

ATC

acetazolamide; systemic

9.5

229.8

281

316

F02.89*G35

ICD-10 Finland

Dementia in multiple sclerosis

103.5

195.5

101

2AB04, ,

NOMESCO Finland

46.8

194.5

114

M03BX01

ATC

baclofen; systemic

8.4

184.6

248

313

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

7.8

184.1

263

357

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

17.0

180.8

151

XA800

NOMESCO Finland

Neuropsychological investigation

4.9

165.4

385

842

L04AG12

ATC

ofatumumab; parenteral

87.8

163.2

Z3229

NOMESCO Finland

Other healthcare associate professional

3.5

144.7

551

1726

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

8.8

132.7

169

199

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

39.2

125.8

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

21.3

125.5

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

6.3

124.1

216

361

36703

ICD-8 Finland

Inflammation of optic nerve and retina, Neuritis optica, retrobulbaris

+∞

121.4

116

H48.1*G35

ICD-10 Finland

Retrobulbar neuritis in multiple sclerosis

+∞

121.4

116

L04AK02

ATC

teriflunomide; oral

45.1

120.0

N06BA07

ATC

modafinil; oral

19.0

118.0

H53.9

ICD-10 Finland

Visual disturbance, unspecified

4.4

115.9

303

724

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

7.5

114.6

166

228

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

11.8

110.4

113

4AA23, ,

NOMESCO Finland

60.9

107.6

AA1AD

NOMESCO Finland

CT of head and brain

2.1

103.8

1303

7282

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.0

103.7

524

1928

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

8.7

103.3

132

156

G36.9

ICD-10 Finland

Acute disseminated demyelination, unspecified

31.9

101.8

Z3231

NOMESCO Finland

Registered nurse

2.1

98.5

1322

7552

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

16.1

95.9

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

9.7

87.6

103

109

XKD06

NOMESCO Finland

Physiologic investigation of micturition

4.8

85.9

201

438

H57.1

ICD-10 Finland

Ocular pain

3.5

83.0

298

889

E23.00

ICD-10 Finland

Panhypopituitarism

14.9

81.1

ZX120

NOMESCO Finland

Intravenous

2.7

81.0

502

2044

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

9.4

75.8

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

6.9

75.0

117

174

3773B

ICD-9 Finland

Disorders of optic nerve and visual pathways, Optic neuritis[NEURITIS RETROBULBARIS]

+∞

74.2

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

8.7

74.0

110

R51.80

ICD-10 Finland

Headache

2.1

73.2

873

4697

PAW37

NOMESCO Finland

Biopsy of temporal artery

12.3

70.3

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

6.1

70.0

123

207

G04BD09

ATC

trospium; oral

5.0

68.9

152

315

G36.0

ICD-10 Finland

Neuromyelitis optica [Devic]

230.3

66.4

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

4.9

65.8

146

304

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

10.2

65.5

H47.7

ICD-10 Finland

Disorder of visual pathways, unspecified

648.1

65.1

3400A

ICD-9 Finland

Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]

118.6

65.0

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

7.9

62.5

111

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

8.3

62.5

100

H53.2

ICD-10 Finland

Diplopia

3.7

61.4

204

577

XKD00

NOMESCO Finland

Uroflowmetry

2.2

59.7

590

2935

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.8

59.7

314

1170

ZXA10

NOMESCO Finland

Bilateral

2.0

59.4

800

4462

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

58.9

373

1527

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

5.9

58.7

106

183

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

57.7

1900

13800

H54.4

ICD-10 Finland

Blindness, monocular

14.9

56.2

L03AB13

ATC

peginterferon beta-1a; parenteral

70.9

55.2

L04AE01

ATC

fingolimod; oral

101.5

54.9

H02AB04

ATC

methylprednisolone; systemic

2.0

54.8

651

3464

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.7

54.8

323

1275

H54.7

ICD-10 Finland

Unspecified visual loss

7.9

54.4

L04AA40

ATC

cladribine; oral

99.8

53.9

H02AB09

ATC

hydrocortisone; systemic

3.7

53.4

172

476

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

6.3

53.1

146

H34.1

ICD-10 Finland

Central retinal artery occlusion

11.6

52.5

R20.2

ICD-10 Finland

Paraesthesia of skin

2.4

52.5

389

1711

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

7.6

52.2

N03AX12

ATC

[U] gabapentin; oral

2.0

52.1

709

3951

101

Kela drug reimbursment

Anterior pituitary hypofunction

7.0

52.1

114

Z2445

NOMESCO Finland

Psychologist

2.9

51.8

250

888

R1250

NOMESCO Finland

Evaluation of functional capability

3.8

51.6

159

427

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.8

51.5

269

997

N03AX16

ATC

[U] pregabalin

1.8

51.0

958

5913

L04AX01

ATC

azathioprine; systemic

3.0

50.8

239

837

N03AX14

ATC

levetiracetam; systemic

3.6

50.2

168

477

R4150

NOMESCO Finland

Neuropsychological rehabilitation

7.2

50.0

104

36702

ICD-8 Finland

Inflammation of optic nerve and retina, Neuritis optica. Papillitis

+∞

48.0

XKC03

NOMESCO Finland

Water cystometry

3.6

47.8

163

469

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.1

47.2

522

2697

UKC02

NOMESCO Finland

Cystoscopy

2.0

46.9

604

3294

G04BD12

ATC

mirabegron; oral

2.1

46.8

487

2460

H02AB06

ATC

prednisolone; systemic

1.6

46.7

1950

14766

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

46.4

556

2957

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

5.6

46.2

160

L04AA52

ATC

[U] ofatumumab; parenteral

161.8

45.9

A02BC02

ATC

pantoprazole; systemic

1.6

45.5

2776

22921

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

5.2

45.2

185

N03AE01

ATC

clonazepam; systemic

2.6

45.2

278

1119

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

5.5

45.1

160

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.5

44.6

291

1205

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

9.1

44.2

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.8

44.1

137

370

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

44.0

913

5770

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

9.9

43.6

N03AF02

ATC

oxcarbazepine; oral

3.1

43.0

186

620

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

9.7

43.0

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.5

42.5

150

441

G91.1

ICD-10 Finland

Obstructive hydrocephalus

10.3

42.2

N32.83

ICD-10 Finland

Nozzle synergy in the bladder neck

13.6

41.7

G91.0

ICD-10 Finland

Communicating hydrocephalus

9.2

41.3

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

41.3

1670

12441

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

13.1

40.8

37799

ICD-8 Finland

Other diseases of retina and optic nerve, Unspecified

+∞

40.7

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

6.6

40.4

100

Z3226

NOMESCO Finland

Physiotherapist

1.8

39.9

760

4671

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

9.5

39.8

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

39.7

543

3012

R42

ICD-10 Finland

Dizziness and giddiness

1.7

39.7

931

6061

3773A

ICD-9 Finland

Disorders of optic nerve and visual pathways, Optic neuritis[PAPILLITIS OPTICA]

+∞

39.6

F05

ICPC

Visual disturbance other

3.0

39.5

183

635

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.1

39.2

171

573

Z2446

NOMESCO Finland

Social worker

2.3

39.1

328

1516

102

Kela drug reimbursment

Diabetes insipidus

14.0

39.1

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.7

39.0

127

354

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

5.6

39.0

134

XCH00

NOMESCO Finland

Eye pressure measurement

2.7

38.6

217

835

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

8.7

37.9

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

13.6

37.4

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

10.9

37.3

CS2P4

NOMESCO Finland

Optic nerve head imaging

6.3

37.3

102

34099

ICD-8 Finland

Multiple sclerosis

70.5

37.0

TKC22

NOMESCO Finland

Catheterisation instruction

3.8

36.6

113

304

M31.6

ICD-10 Finland

Other giant cell arteritis

13.7

36.5

R4110

NOMESCO Finland

Physiotherapy

1.6

36.3

1113

7724

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

35.2

470

2581

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

34.9

588

3475

G04BD04

ATC

oxybutynin; oral, transdermal

2.5

34.9

224

919

N05CF01

ATC

zopiclone; oral

1.6

34.5

1213

8671

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

9.4

34.5

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

3.7

34.4

108

294

H54.3

ICD-10 Finland

Mild or no visual impairment, binocular

10.7

34.0

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

33.5

632

3858

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

5.2

33.3

132

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

33.2

626

3821

H53.8

ICD-10 Finland

Other visual disturbances

4.1

33.0

230

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.4

32.7

232

997

R4120

NOMESCO Finland

Occupational therapy

2.2

32.4

302

1456

37790

ICD-8 Finland

Other diseases of retina and optic nerve, Atrophia (et degeneratio) nervi optici (tabica excepta)

+∞

32.3

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

32.0

614

3763

R35

ICD-10 Finland

Polyuria

2.2

31.8

284

1346

L28

ICPC

Limited function/disability (L)

1.7

31.6

710

4539

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

11.9

31.6

R33

ICD-10 Finland

Retention of urine

2.2

31.6

291

1396

TKC20

NOMESCO Finland

Catheterisation of bladder

2.3

31.5

262

1206

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

31.3

468

2663

N05BA09

ATC

clobazam; oral

6.0

31.2

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

30.9

1208

8798

SPAT1229

SPAT

Assessment of need for aid

2.1

30.8

291

1409

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

30.8

621

3856

XCD20

NOMESCO Finland

Photoangiography of eye

4.2

30.8

194

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

30.5

581

3550

N03AX11

ATC

topiramate; oral

2.9

30.3

145

512

N99

ICPC

Neurological disease other

4.3

30.0

181

N03AF01

ATC

carbamazepine; oral, rectal

2.4

29.5

205

873

J01EA01

ATC

trimethoprim; systemic

1.5

29.2

1033

7348

G04BD08

ATC

solifenacin; oral

2.2

29.1

247

1146

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

4.2

29.0

190

Z2221

NOMESCO Finland

Medical doctor

1.5

28.9

1108

8015

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

8.5

28.7

H54.1

ICD-10 Finland

Severe visual impairment, binocular

48.9

28.4

N28

ICPC

Limited function/disability (N)

3.6

28.4

261

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.1

28.3

292

1462

A28

ICPC

Limited function/disability NOS

1.7

28.3

615

3891

H47.4

ICD-10 Finland

Disorders of optic chiasm

+∞

28.2

CA1DG

NOMESCO Finland

Eye and orbita very extensive MRI examination with high intensity magnet

31.1

28.1

N02BF01

ATC

gabapentin; oral

1.8

28.0

440

2537

H34.8

ICD-10 Finland

Other retinal vascular occlusions

3.5

27.9

288

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

27.8

990

7040

N02AX02

ATC

tramadol; systemic, rectal

1.4

27.7

1596

12492

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

27.4

645

4162

N06AX16

ATC

venlafaxine; oral

1.7

27.4

623

3986

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

27.1

1331

10095

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

9.8

26.8

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

5.5

26.8

C03CA01

ATC

furosemide; systemic

1.5

26.6

948

6731

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.4

26.4

279

H50.1

ICD-10 Finland

Divergent concomitant strabismus

5.4

26.2

R50.9

ICD-10 Finland

Fever, unspecified

1.6

26.1

636

4137

H20.1

ICD-10 Finland

Chronic iridocyclitis

4.2

25.6

164

H26.4

ICD-10 Finland

After-cataract

1.9

25.6

339

1852

G04BD07

ATC

tolterodine; oral

2.4

25.5

180

772

H02AB07

ATC

prednisone; oral

1.7

25.4

510

3154

H30.2

ICD-10 Finland

Posterior cyclitis

8.0

25.1

N02BE01

ATC

paracetamol; systemic, rectal

1.6

25.0

3616

33274

C10AC01

ATC

colestyramine; oral

2.8

25.0

129

475

H54.5

ICD-10 Finland

Severe visual impairment, monocular

6.4

24.8

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.4

24.7

256

R5110, ,

SPAT

1.9

24.7

328

1792

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

24.6

952

6863

A02BC01

ATC

omeprazole; systemic

1.5

24.5

1002

7303

ZXC95

NOMESCO Finland

Use of surgical navigator

4.1

24.5

161

WX882

NOMESCO Finland

High dependency care

2.7

24.4

136

521

ZXD05

NOMESCO Finland

Urgent procedure

1.5

24.3

1185

8936

G44.2

ICD-10 Finland

Tension-type headache

1.6

24.2

595

3871

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

3.9

24.0

181

37791

ICD-8 Finland

Other diseases of retina and optic nerve, Papilloedema. Stasis papillae

+∞

24.0

H52.1

ICD-10 Finland

Myopia

2.3

23.9

192

871

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.0

23.7

108

372

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

23.6

345

1943

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

3.9

23.5

175

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.3

23.5

145

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.1

23.2

328

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

2.8

23.2

113

404

P85

ICPC

Mental retardation

8.4

23.1

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

22.8

487

3055

N03AX09

ATC

lamotrigine; oral

2.1

22.8

235

1175

G50.0

ICD-10 Finland

Trigeminal neuralgia

3.2

22.8

295

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

22.8

206

980

H54.0

ICD-10 Finland

Blindness, binocular

26.0

22.6

XKD03

NOMESCO Finland

Urethral pressure profilometry

3.1

22.6

307

H54.6

ICD-10 Finland

Moderate visual impairment, monocular

7.8

22.5

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.8

22.5

341

1943

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

4.5

22.2

118

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.3

22.1

169

751

H48.1

ICD-10 Finland

Retrobulbar neuritis in diseases classified elsewhere

+∞

21.9

H47

ICD-10 Finland

Other disorders of optic [2nd] nerve and visual pathways

+∞

21.9

N06AX21

ATC

duloxetine; oral

1.7

21.8

486

3081

WX892

NOMESCO Finland

Monitored bed care

1.9

21.8

286

1556

G04CA02

ATC

tamsulosin; oral

1.6

21.7

659

4499

114

Kela drug reimbursment

Glaucoma

1.9

21.5

277

1497

N03AG01

ATC

valproic acid; systemic, rectal

2.0

21.4

248

1293

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

5.4

21.3

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

7.9

21.3

N03AX18

ATC

lacosamide; systemic

4.6

21.2

110

A02BC03

ATC

lansoprazole; oral

1.4

21.2

989

7365

N29

ICPC

Neurological sympt/complt other

3.0

21.2

319

D44.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pituitary gland

8.5

21.0

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

20.9

1012

7585

XCW12

NOMESCO Finland

Assessment of colour vision

28.2

20.9

H47.6

ICD-10 Finland

Disorders of visual cortex

+∞

20.8

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

20.4

872

6381

PA2AD

NOMESCO Finland

CT angiography of brain

4.1

20.4

139

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.4

20.2

138

583

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.2

20.2

171

793

H40.0

ICD-10 Finland

Glaucoma suspect

1.9

20.2

283

1573

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

20.1

793

5709

S01ED51

ATC

timolol, combinations; ophthalmic

1.9

20.1

246

1308

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

20.0

171

796

M03BX02

ATC

tizanidine; oral

1.4

20.0

2418

20997

J01FF01

ATC

clindamycin; systemic

1.4

19.9

991

7458

ZXE00

NOMESCO Finland

One hour or less

1.4

19.5

1479

11936

G03.9

ICD-10 Finland

Meningitis, unspecified

7.4

19.5

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

19.5

332

1956

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

5.2

19.4

A06AD11

ATC

lactulose; oral

1.6

19.2

479

3119

D35.30

ICD-10 Finland

Craniopharyngoma

46.2

19.2

J01MA02

ATC

ciprofloxacin; systemic

1.4

19.1

1369

10945

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

3.2

19.0

243

J01AA02

ATC

doxycycline; systemic

1.4

19.0

2976

26788

H53.0

ICD-10 Finland

Amblyopia ex anopsia

3.8

18.9

156

3771A

ICD-9 Finland

Disorders of optic nerve and visual pathways, Optic atrophy

+∞

18.8

H01AC01

ATC

somatropin; parenteral

5.2

18.6

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

18.6

1022

7814

183

Kela drug reimbursment

Lamotrigin and topiramate

3.9

18.5

136

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

3.7

18.3

155

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

18.2

417

2657

H34.2

ICD-10 Finland

Other retinal artery occlusions

5.3

18.2

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

18.1

2923

26308

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

18.1

883

6602

D32.01

ICD-10 Finland

Benign tumor of meninges on interhemispheric surface

6.1

18.1

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

18.0

368

2280

OAB50, ,

SPAT

1.8

17.9

292

1698

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

17.9

1356

10910

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

17.9

1617

13361

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

7.3

17.8

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.1

17.8

232

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

17.8

1103

8595

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

3.4

17.6

183

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

17.6

1472

12016

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

17.5

221

1187

6BA02, ,

NOMESCO Finland

7.1

17.4

RS222, ,

NOMESCO Finland

3.5

17.3

166

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.7

17.3

334

N06AB04

ATC

citalopram; systemic

1.4

17.2

759

5569

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

4.2

17.2

108

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

3.4

17.1

182

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

17.1

344

2122

CKC12

NOMESCO Finland

Photocoagulation of retina

2.1

17.0

153

727

N06AA09

ATC

amitriptyline; systemic

1.7

17.0

323

1961

H35.5

ICD-10 Finland

Hereditary retinal dystrophy

6.9

17.0

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

4.1

16.8

110

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

16.7

747

5489

R4190

NOMESCO Finland

Nutritional therapy

2.0

16.7

184

944

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

16.7

446

2949

H47.5

ICD-10 Finland

Disorders of other visual pathways

+∞

16.7

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

16.7

222

1214

N05BA01

ATC

diazepam; systemic, rectal

1.6

16.6

448

2969

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

5.3

16.5

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.4

16.5

176

SPAT1216

SPAT

Assessment of functional ability

1.5

16.4

496

3371

A02BA02

ATC

ranitidine; systemic

1.5

16.4

614

4362

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.7

16.2

324

1994

SPAT1301

SPAT

No procedures

1.4

16.2

1112

8785

L04AA06

ATC

mycophenolic acid; systemic

2.7

16.1

324

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

16.0

1437

11806

R60.0

ICD-10 Finland

Localized oedema

1.6

15.9

438

2916

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

3.7

15.8

133

U13

ICPC

Bladder symptom/complaint other

2.3

15.8

119

527

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

6.9

15.7

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

15.5

393

2564

H40.11

ICD-10 Finland

Low pressure glaucoma

2.8

15.5

290

XCW10

NOMESCO Finland

Assessment of vision

3.2

15.4

194

N30.0

ICD-10 Finland

Acute cystitis

1.4

15.4

674

4927

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

15.4

1429

11785

W19

ICD-10 Finland

Unspecified fall

1.6

15.4

359

2298

ZXA00

NOMESCO Finland

Right side

1.4

15.4

847

6449

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

2.2

15.4

124

565

J01DA01

ATC

[U] cefalexin

1.3

15.4

2324

20468

ZXC86

NOMESCO Finland

Use of endoscopic device

5.2

15.3

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.0

15.3

162

820

R06.0

ICD-10 Finland

Dyspnoea

1.4

15.3

959

7459

9530/0-C70.9

ICD-O-3

Meningioma, NOS, of meninges, NOS

16.1

15.2

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.7

15.2

316

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

15.2

343

2178

N03AB02

ATC

phenytoin; systemic

3.7

15.0

124

H52.0

ICD-10 Finland

Hypermetropia

2.5

15.0

401

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

14.9

532

3741

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

14.8

244

1424

SPAT1262

SPAT

Handing over of treatment supplies

1.5

14.8

555

3940

L04AX09

ATC

diroximel fumarate; oral

56.9

14.8

RK110, ,

NOMESCO Finland

4.3

14.8

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

14.8

1049

8309

CK2P4

NOMESCO Finland

Optic nerve head light layer imaging (OCT)

5.0

14.8

S01ED01

ATC

timolol; ophthalmic

2.3

14.7

110

485

J01DB01

ATC

cefalexin; oral

1.4

14.7

3294

30536

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.4

14.6

400

H48.1*A69.2

ICD-10 Finland

Retrobulbar neuritis in Lyme disease

+∞

14.6

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.0

14.5

156

793

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

14.5

238

1386

R39.1

ICD-10 Finland

Other difficulties with micturition

2.3

14.5

107

470

N05BA04

ATC

oxazepam; oral

1.4

14.4

962

7541

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

14.4

1159

9344

RS221, ,

NOMESCO Finland

2.9

14.4

229

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

14.3

174

925

G80.1

ICD-10 Finland

Spastic diplegic cerebral palsy

27.3

14.3

CA1ME

NOMESCO Finland

Ultrasound oculometry

4.7

14.2

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

14.1

2132

18687

U05

ICPC

Urination problems other

1.9

14.0

185

1010

S01EE01

ATC

latanoprost; ophthalmic

1.9

13.9

189

1040

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

10.1

13.9

J01CA08

ATC

pivmecillinam; oral

1.3

13.9

1589

13427

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

4.2

13.9

H51.2

ICD-10 Finland

Internuclear ophthalmoplegia

17.6

13.8

A04

ICPC

Weakness/tiredness general

1.4

13.8

621

4559

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

3.5

13.7

137

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

3.5

13.7

137

E23.05

ICD-10 Finland

Lack of TSH

5.7

13.7

J01MA12

ATC

levofloxacin; systemic

1.4

13.6

599

4379

RD210, ,

NOMESCO Finland

2.5

13.5

335

36709

ICD-8 Finland

Inflammation of optic nerve and retina, Unspecified

+∞

13.5

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

3.6

13.5

124

G97.1

ICD-10 Finland

Other reaction to spinal and lumbar puncture

10.1

13.4

SPAT1153

SPAT

Removal of sutures

1.3

13.4

1032

8252

U07

ICPC

Urine symptom/complaint other

1.6

13.4

307

1957

G80.9

ICD-10 Finland

Cerebral palsy, unspecified

18.3

13.3

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

5.3

13.2

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

13.2

1589

13490

E66.8

ICD-10 Finland

Other obesity

1.7

13.2

229

1356

WX002

NOMESCO Finland

Sedation and analgesia

1.4

13.2

625

4628

H25.8

ICD-10 Finland

Other senile cataract

1.6

13.2

305

1948

ZXY02

NOMESCO Finland

Neuropsychologist

4.3

13.1

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.9

13.1

214

WX872

NOMESCO Finland

Intensive care

1.9

13.1

158

838

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

13.0

398

2708

H50.31

ICD-10 Finland

Intermittent exotropia

3.4

13.0

137

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

13.0

890

6994

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

13.0

360

2398

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

13.0

351

2325

M05BA04

ATC

alendronic acid; oral

1.7

12.9

256

1571

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

12.9

675

5078

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

12.9

345

2277

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

13.0

12.9

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

12.9

662

4968

H35.0

ICD-10 Finland

Background retinopathy and retinal vascular changes

4.5

12.8

XCH05

NOMESCO Finland

Eye pressure longterm registration

3.7

12.7

110

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.7

12.7

225

1341

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.5

12.7

364

2442

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.4

12.6

365

R51

ICD-10 Finland

Headache

1.7

12.6

237

1435

S18

ICPC

Laceration/cut

1.3

12.6

1669

14317

R52.9

ICD-10 Finland

Pain, unspecified

1.5

12.6

377

2553

PA6AD

NOMESCO Finland

CT of neck arteries

2.0

12.6

133

674

RF120, ,

NOMESCO Finland

3.1

12.5

166

R51.81

ICD-10 Finland

Facial pain NOS

2.2

12.4

102

469

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.3

12.4

418

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.0

12.4

124

616

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.9

12.3

N18

ICPC

Paralysis/weakness

2.5

12.3

291

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

3.8

12.3

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

4.2

12.2

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

12.2

399

2751

G04BD11

ATC

fesoterodine; oral

2.3

12.2

383

A10AB05

ATC

insulin aspart; parenteral

1.6

12.2

263

1650

L01BB04

ATC

cladribine; systemic

37.6

12.2

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.5

12.2

292

F83

ICD-10 Finland

Mixed specific developmental disorders

3.8

12.2

N06AX11

ATC

mirtazapine; oral

1.3

12.1

1239

10273

S01EA05

ATC

brimonidine; ophthalmic

2.4

12.1

323

H50.0

ICD-10 Finland

Convergent concomitant strabismus

3.5

12.1

119

R11

ICD-10 Finland

Nausea and vomiting

1.5

12.1

339

2264

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

3.1

12.1

154

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.8

12.0

213

Z50.1

ICD-10 Finland

Other physical therapy

1.8

12.0

178

1007

C08CA01

ATC

amlodipine; oral

1.3

12.0

1175

9685

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

12.0

1068

8694

G96.0

ICD-10 Finland

Cerebrospinal fluid leak

11.1

12.0

4AA36, ,

NOMESCO Finland

46.8

11.9

WW400

NOMESCO Finland

Plasmaferesis

11.7

11.8

G40.10

ICD-10 Finland

Simple partial seizures

3.9

11.8

C07AB07

ATC

bisoprolol; oral

1.3

11.7

1548

13241

S97

ICPC

Chronic ulcer skin

1.7

11.7

195

1143

WX402

NOMESCO Finland

General anaesthesia

1.3

11.7

826

6510

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

1.9

11.6

139

735

ABD40

NOMESCO Finland

Implantation of spinal injection device

30.1

11.6

AA2DG

NOMESCO Finland

Very extensive magnetic examination of the head and orbit

30.1

11.6

ZXA05

NOMESCO Finland

Left side

1.3

11.6

756

5882

R4130

NOMESCO Finland

Speech therapy

2.1

11.6

102

482

K02.1

ICD-10 Finland

Caries of dentine

1.3

11.6

2349

21097

B01AB05

ATC

enoxaparin; parenteral

1.3

11.6

1030

8375

H53

ICD-10 Finland

Visual disturbances

3.2

11.6

142

L17

ICPC

Foot/toe symptom/complaint

1.3

11.6

1113

9145

S01EC04

ATC

brinzolamide; ophthalmic

2.0

11.6

119

597

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

11.5

720

5566

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.7

11.5

218

R13

ICD-10 Finland

Dysphagia

1.6

11.5

242

1509

H03AA01

ATC

levothyroxine sodium; systemic

1.3

11.5

818

6450

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.4

11.5

123

A46

ICD-10 Finland

Erysipelas

1.4

11.4

452

3234

G91.8

ICD-10 Finland

Other hydrocephalus

13.6

11.4

A02BC05

ATC

esomeprazole; systemic

1.3

11.4

1416

12009

AAF10

NOMESCO Finland

Lumboperitoneal shunt

120.3

11.4

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.9

11.4

153

841

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.2

11.3

428

3AX01, ,

NOMESCO Finland

5.4

11.3

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.3

11.2

353

R62.0

ICD-10 Finland

Delayed milestone

3.7

11.2

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

4.9

11.2

XA412

NOMESCO Finland

VEP

17.1

11.2

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.0

11.1

112

558

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

11.1

502

3679

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.7

11.1

183

1069

SPAT1254

SPAT

Administration of medicine

1.4

11.1

499

3657

H15.0

ICD-10 Finland

Scleritis

5.3

11.1

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.9

11.0

131

692

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.6

11.0

240

1512

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

10.9

319

2150

F99

ICPC

Eye/adnexa disease other

3.7

10.8

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

10.8

216

1330

Z71.8

ICD-10 Finland

Other specified counselling

1.3

10.8

1329

11247

SPAT1263

SPAT

Sampling

1.3

10.8

1514

13009

301

Kela drug reimbursment

Growth hormone

8.8

10.7

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

10.7

146

806

G82.2

ICD-10 Finland

Paraplegia, unspecified

4.4

10.7

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.3

10.7

323

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

10.7

808

6420

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

10.7

353

2440

R01AD09

ATC

mometasone; nasal

1.2

10.7

1738

15181

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

10.6

243

1547

RK320, ,

NOMESCO Finland

3.8

10.6

D32.03

ICD-10 Finland

Benign meningioma in ventricles

12.9

10.6

127

Kela drug reimbursment

Transplant complication

2.6

10.6

240

TK800

NOMESCO Finland

Hemodialysis

2.4

10.5

295

R3120

NOMESCO Finland

Training in mobility skills

4.5

10.5

V03AE02

ATC

sevelamer; oral

4.5

10.5

R02

ICPC

Shortness of breath/dyspnoea

1.4

10.5

468

3424

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.2

10.4

371

U04

ICPC

Incontinence urine

1.7

10.4

188

1127

3774A

ICD-9 Finland

Disorders of optic nerve and visual pathways, Other disorders of optic nerve

+∞

10.4

C72.3

ICD-10 Finland

Malignant neoplasm: Optic nerve

+∞

10.4

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

4.1

10.4

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.7

10.4

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

10.4

671

5211

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

10.3

994

8150

Z43.5

ICD-10 Finland

Attention to cystostomy

4.2

10.3

G93.0

ICD-10 Finland

Cerebral cysts

4.3

10.3

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.3

10.3

323

Z94.0

ICD-10 Finland

Kidney transplant status

2.9

10.3

164

M79.6

ICD-10 Finland

Pain in limb

1.2

10.2

1642

14295

D12

ICPC

Constipation

1.9

10.2

128

688

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

4.5

10.2

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.2

10.2

368

SFA30

NOMESCO Finland

Three-surface restoration

1.2

10.1

1510

13035

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

3.4

10.1

108

U02

ICPC

Urinary frequency/urgency

1.4

10.1

535

4027

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

10.1

273

1809

G50.1

ICD-10 Finland

Atypical facial pain

2.3

10.1

307

G44.0

ICD-10 Finland

Cluster headache syndrome

2.7

10.0

194

RS122, ,

NOMESCO Finland

5.0

10.0

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.5

10.0

247

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

10.0

477

3529

H52.2

ICD-10 Finland

Astigmatism

2.2

9.9

379

N01

ICPC

Headache

1.4

9.9

479

3551

CEC60

NOMESCO Finland

Transposition of extraocular muscle with adjustable suture

16.7

9.9

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.0

9.8

141

F29

ICPC

Eye symptom/complaint other

1.4

9.8

388

2775

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

9.8

193

1185

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

9.8

405

2921

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

4.9

9.8

S29

ICPC

Skin symptom/complaint other

1.3

9.7

719

5686

S01EE05

ATC

tafluprost; ophthalmic

2.0

9.7

107

551

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

3.5

9.7

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.2

9.7

121

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

9.7

374

2664

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

9.7

1190

10041

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

3.0

9.7

137

G51.0

ICD-10 Finland

Bell palsy

2.1

9.7

450

CK9F4

NOMESCO Finland

Fluorescein angiography (FAG) of choroid and retina

3.6

9.6

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

9.6

2878

26701

G40.89

ICD-10 Finland

Other epilepsy

4.2

9.6

R53

ICD-10 Finland

Malaise and fatigue

1.3

9.6

950

7808

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.9

9.6

122

661

SPAT1260

SPAT

Consultation of another employee

1.3

9.5

578

4440

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.2

9.5

379

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

9.5

839

6794

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

9.5

274

1840

D32.04

ICD-10 Finland

Secondary or multiple benign tumor of the meninges above the exam

15.0

9.5

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.7

9.5

159

935

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.7

9.5

175

1057

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

9.4

246

1616

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.2

9.4

374

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

3.0

9.4

139

J01CA04

ATC

amoxicillin; systemic

1.3

9.4

3290

31022

AA1AA

NOMESCO Finland

Head X-ray examination

3.2

9.4

113

PH4YT

NOMESCO Finland

Dilatation of vein of head or brain

100.3

9.4

CA1BM

NOMESCO Finland

Eye and orbita MRI examination with 3 Tesla magnet

100.3

9.4

3313A

ICD-9 Finland

Other cerebral degenerations, Communicating hydrocephalus

100.3

9.4

A10AE04

ATC

insulin glargine; parenteral

1.5

9.4

299

2050

S06.0

ICD-10 Finland

Concussion

1.4

9.4

384

2763

N02BF02

ATC

pregabalin; oral

1.6

9.4

239

1562

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

9.4

2009

17977

3770A

ICD-9 Finland

Disorders of optic nerve and visual pathways, Papilloedema

+∞

9.4

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

9.4

1490

12926

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

9.4

205

1293

S01EE04

ATC

travoprost; ophthalmic

2.4

9.3

243

WX290

NOMESCO Finland

Other blockage of nerve

1.2

9.3

1879

16708

UJF32

NOMESCO Finland

Coloscopy

1.3

9.3

815

6593

RT150, ,

NOMESCO Finland

4.7

9.3

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

9.3

663

5217

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

8.7

9.3

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.1

9.2

431

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.1

9.2

385

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

3.5

9.2

137

Kela drug reimbursment

Uraemia requiring dialysis

3.1

9.2

115

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.7

9.2

169

L04AD02

ATC

tacrolimus; systemic

2.7

9.2

169

R06AE07

ATC

cetirizine; oral

1.2

9.2

1659

14580

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

4.2

9.2

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

9.1

296

2039

F01

ICPC

Eye pain

1.9

9.1

115

622

G43.9

ICD-10 Finland

Migraine, unspecified

1.5

9.1

259

1737

A10AC01

ATC

insulin (human); parenteral

1.5

9.1

240

1583

E66.01

ICD-10 Finland

Obesity due to excess calories

1.4

9.1

363

2603

N88

ICPC

Epilepsy

3.5

9.1

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

9.1

218

1407

8000/0-C70.0

ICD-O-3

Neoplasm, benign of cerebral meninges

4.6

9.1

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.1

9.0

116

CEW99

NOMESCO Finland

Other operation on extraocular muscle

15.6

9.0

E23.2

ICD-10 Finland

Diabetes insipidus

7.0

9.0

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.0

9.0

511

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

9.0

942

7791

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.7

9.0

174

1065

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

9.0

209

1339

U08

ICPC

Urinary retention

2.3

9.0

279

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

8.9

915

7545

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

8.9

136

779

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.6

8.9

182

1129

F94

ICPC

Blindness

24.0

8.9

G80.0

ICD-10 Finland

Spastic quadriplegic cerebral palsy

24.0

8.9

SPAT1255

SPAT

Intravenous administration of medicine

1.6

8.9

209

1342

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

8.9

197

1248

SFA20

NOMESCO Finland

Two-surface restoration

1.2

8.8

2251

20447

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

8.8

406

2985

R60.9

ICD-10 Finland

Oedema, unspecified

1.6

8.8

182

1133

H30.9

ICD-10 Finland

Chorioretinal inflammation, unspecified

10.7

8.8

AA1AM

NOMESCO Finland

Short MRI examination of brain with 3 Tesla magnet

10.7

8.8

H25.0

ICD-10 Finland

Senile incipient cataract

1.6

8.7

184

1150

S10

ICPC

Boil/carbuncle

1.6

8.7

207

1333

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.7

8.7

174

KCW98

NOMESCO Finland

Other transluminal endoscopic operation on bladder

14.0

8.7

H35.8

ICD-10 Finland

Other specified retinal disorders

3.9

8.7

9350/1-C75.2

ICD-O-3

Craniopharyngioma, NOS, of craniopharyngeal duct

50.1

8.7

NA1BM

NOMESCO Finland

Cervical spine MRI examination with 3 Tesla magnet

7.6

8.6

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

8.6

515

3946

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

4.6

8.6

G37.8

ICD-10 Finland

Other specified demyelinating diseases of central nervous system

16.3

8.5

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

2.5

8.5

217

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

2.7

8.5

159

D32

ICD-10 Finland

Benign neoplasm of meninges

27.6

8.5

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

8.5

297

2077

B05DA

ATC

Isotonic solutions

3.3

8.5

NA1CM

NOMESCO Finland

Cervical spine extensive MRI examination with 3 Tesla magnet

6.4

8.5

J01FA06

ATC

roxithromycin; oral

1.2

8.5

1365

11829

R5599

NOMESCO Finland

Other rehabilitation service

1.9

8.4

100

530

H26.2

ICD-10 Finland

Complicated cataract

2.6

8.4

177

34109

ICD-8 Finland

Other demyelinating diseases of central nervous system, Unspecified

90.2

8.4

SFA10

NOMESCO Finland

One-surface restoration

1.2

8.4

2118

19176

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

8.4

1734

15401

M05BX04

ATC

denosumab; parenteral

1.6

8.4

176

1100

N02AA05

ATC

oxycodone; systemic

1.3

8.4

531

4105

NA7CM

NOMESCO Finland

Spine and spinal cord extensive MRI examination with 3 Tesla magnet

12.8

8.4

3773X

ICD-9 Finland

Disorders of optic nerve and visual pathways, Optic neuritis[NEURITIS OPTICA ALIA SEU NUD]

+∞

8.3

3772A

ICD-9 Finland

Disorders of optic nerve and visual pathways, Other disorders of optic disk

+∞

8.3

A97

ICPC

No disease

1.3

8.3

715

5762

F82

ICD-10 Finland

Specific developmental disorder of motor function

4.0

8.3

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.6

8.3

171

1063

M41.4

ICD-10 Finland

Neuromuscular scoliosis

10.7

8.3

AAA27

NOMESCO Finland

Insertion of intracerebral pressure monitoring device

9.4

8.3

WX704

NOMESCO Finland

Intubation

1.5

8.2

269

1855

H01

ICPC

Ear pain/earache

1.4

8.2

457

3463

9531/0-C70.0

ICD-O-3

Meningothelial meningioma of cerebral meninges

14.5

8.2

TJD20

NOMESCO Finland

Change of gastrostomy tube

4.2

8.2

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.7

8.2

135

792

D33.30

ICD-10 Finland

Acoustic neuroma

3.7

8.2

Q85.00

ICD-10 Finland

Neurofibromatosis, type 1

7.5

8.1

B01AC04

ATC

clopidogrel; oral

1.4

8.1

432

3250

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

8.1

454

3445

N18.8

ICD-10 Finland

Other chronic renal failure

2.1

8.1

331

2132

FHL

Ventricular operators sunt

33.4

8.1

G53.2*D86.8

ICD-10 Finland

Multiple cranial nerve palsies in sarcoidosis

33.4

8.1

E89.30

ICD-10 Finland

Postprocedural hypopituitarism

17.2

8.1

Q87.88

ICD-10 Finland

Other specified congenital malformation syndromes, not elsewhere classified

11.7

8.1

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

8.0

452

3430

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

10.0

8.0

G47.3

ICD-10 Finland

Sleep apnoea

1.3

8.0

727

5898

H51.9

ICD-10 Finland

Disorder of binocular movement, unspecified

22.1

8.0

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.5

7.9

247

1687

R32

ICD-10 Finland

Unspecified urinary incontinence

2.0

7.9

442

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

4.3

7.9

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

7.9

216

1435

R4110, ,

SPAT

1.4

7.9

433

3272

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.6

7.9

156

960

N05CD08

ATC

midazolam; nasal, systemic

2.1

7.9

361

SPAT1293

SPAT

Other function in accordance with rehabilitation guidance nomenclature

3.7

7.9

XX4AW, ,

NOMESCO Finland

4.4

7.9

SPAT1325

SPAT

Vaccination

1.2

7.9

1082

9206

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

3.0

7.9

110

KH1AD

NOMESCO Finland

CT of urinary organs

1.8

7.9

111

622

J01MA14

ATC

moxifloxacin; systemic

1.5

7.9

277

1940

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

7.9

1408

12311

Z02.7

ICD-10 Finland

Issue of medical certificate

1.5

7.8

249

1708

J01MA06

ATC

norfloxacin; oral

1.4

7.8

403

3016

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

8.4

7.8

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

4.1

7.8

I50.0

ICD-10 Finland

Congestive heart failure

1.6

7.8

180

1152

N06AB03

ATC

fluoxetine; oral

1.4

7.8

410

3080

ZXC40

NOMESCO Finland

Use of ultrasound

3.4

7.8

RT274, ,

NOMESCO Finland

9.4

7.8

L86

ICPC

Back syndrome with radiating pain

1.5

7.8

208

1377

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.9

7.7

122

602

Kela drug reimbursment

Children's severe malnutrition

3.7

7.7

9380/3-C71.9

ICD-O-3

Glioma, malignant of brain, NOS

45.1

7.7

E22.80

ICD-10 Finland

Central precocious puberty

15.0

7.7

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

7.7

1340

11682

J02AC01

ATC

fluconazole; systemic

1.2

7.6

1460

12836

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

2.2

7.6

273

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.3

7.6

B05DB

ATC

Hypertonic solutions

3.3

7.6

N04BC05

ATC

pramipexole; oral

1.5

7.6

224

1512

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

7.6

737

6023

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.3

7.6

248

G44.8

ICD-10 Finland

Other specified headache syndromes

2.1

7.6

313

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

7.6

126

741

E23.06

ICD-10 Finland

Empty sella

8.0

7.6

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.7

7.6

142

863

AAF15

NOMESCO Finland

Ventriculoatrial shunt

6.7

7.6

A01

ICPC

Pain general/multiple sites

1.4

7.6

343

2514

CEC10

NOMESCO Finland

Recession and resection of extraocular muscle

3.1

7.5

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

4.1

7.5

G80.2

ICD-10 Finland

Spastic hemiplegic cerebral palsy

10.0

7.5

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.1

7.5

341

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

7.5

356

2629

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.6

7.5

147

904

J01DA09

ATC

[U] cefadroxil

1.2

7.5

890

7449

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.4

7.5

200

R01AD08

ATC

fluticasone; nasal

1.2

7.5

1023

8693

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

7.5

707

5761

A10AE05

ATC

insulin detemir; parenteral

1.6

7.5

164

1038

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

7.4

253

1760

AA2CG

NOMESCO Finland

Extensive magnetic examination of the head and orbit

80.2

7.4

Q85.1

ICD-10 Finland

Tuberous sclerosis

80.2

7.4

G37.0

ICD-10 Finland

Diffuse sclerosis

80.2

7.4

AA5PD

NOMESCO Finland

CT examination of brain pefusion

2.8

7.4

125

S01EE03

ATC

bimatoprost; ophthalmic

2.1

7.4

323

RL140, ,

NOMESCO Finland

6.5

7.4

Z73.6

ICD-10 Finland

Limitation of activities due to disability

3.1

7.4

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.8

7.4

107

605

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.7

7.4

126

747

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

7.4

719

5881

R31

ICD-10 Finland

Unspecified haematuria

1.4

7.4

281

1998

H40.9

ICD-10 Finland

Glaucoma, unspecified

2.3

7.3

233

E0000UV, ,

ATC

1.2

7.3

1528

13531

H3603, E103,

ICD-10 Finland

2.7

7.3

137

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

2.9

7.3

115

H53.5

ICD-10 Finland

Colour vision deficiencies

8.4

7.3

H53.3

ICD-10 Finland

Other disorders of binocular vision

3.6

7.3

CK2M4

NOMESCO Finland

Macular light layer imaging (OCT)

2.9

7.3

110

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.8

7.2

105

594

WX140

NOMESCO Finland

Parabulbar anesthesy

1.7

7.2

131

789

N05CD07

ATC

temazepam; oral

1.4

7.2

300

2166

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.7

7.2

130

782

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

4.3

7.2

UDM02

NOMESCO Finland

Sinoscopy

2.0

7.2

381

S04.0

ICD-10 Finland

Injury of optic nerve and pathways

30.1

7.1

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

7.1

668

5435

F72.0

ICD-10 Finland

Severe mental retardation, with the statement of no, or minimal, impairment of behaviour

20.0

7.1

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.5

7.1

248

1734

R2110

NOMESCO Finland

Giving the first information

1.5

7.1

231

1593

RF420, ,

NOMESCO Finland

2.4

7.1

199

SPAT1360

SPAT

Extensive global examination

1.5

7.1

204

1373

SPAT1211

SPAT

Application of soft bandage

1.4

7.1

276

1971

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.6

7.0

137

842

L02

ICPC

Back symptom/complaint

1.4

7.0

378

2851

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

7.0

898

7575

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

3.5

7.0

ZY010

NOMESCO Finland

Hospital outpatient

1.5

7.0

195

1305

H50.30

ICD-10 Finland

Intermittent esotropy

3.3

7.0

K08.3

ICD-10 Finland

Retained dental root

1.5

6.9

231

1601

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

6.9

251

1768

N07AA03

ATC

distigmine; systemic

6.3

6.9

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

6.3

6.9

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.7

6.9

118

700

JN4AD

NOMESCO Finland

Body CT examination

1.4

6.9

326

2406

Z01.2

ICD-10 Finland

Dental examination

1.2

6.9

1799

16228

WYA10

NOMESCO Finland

Emergency care or similar visit

1.4

6.9

253

1786

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

7.5

6.9

2273A

ICD-9 Finland

Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)

13.8

6.9

N05AH04

ATC

quetiapine; oral

1.3

6.9

621

5029

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

6.9

176

1155

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.8

6.9

102

582

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

6.9

220

1514

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.6

6.8

148

S01EC03

ATC

dorzolamide; ophthalmic

2.5

6.8

166

G04CA01

ATC

alfuzosin; oral

1.4

6.8

294

2138

M05BA07

ATC

risedronic acid; oral

1.9

6.8

389

G45.3

ICD-10 Finland

Amaurosis fugax

2.2

6.8

267

G04.8

ICD-10 Finland

Other encephalitis, myelitis and encephalomyelitis

10.9

6.8

SPAT1312

SPAT

General health counselling

1.2

6.8

1116

9649

WX725

NOMESCO Finland

Noninvasive ventilation

1.5

6.8

178

1175

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

6.8

918

7784

J05AB01

ATC

aciclovir; systemic

1.2

6.8

750

6223

J01FA10

ATC

azithromycin; systemic

1.2

6.8

2195

20167

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.7

6.8

123

743

G80.8

ICD-10 Finland

Other cerebral palsy

40.1

6.8

CK2K4

NOMESCO Finland

Red-free imaging of ocular fundus

5.6

6.7

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

4.3

6.7

Q85.0

ICD-10 Finland

Neurofibromatosis (nonmalignant)

16.7

6.7

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

6.7

237

1661

R03AC12

ATC

salmeterol; inhalant

1.7

6.7

125

759

N05BA12

ATC

alprazolam; oral

1.4

6.7

309

2271

R05

ICPC

Cough

1.2

6.7

904

7658

M54.5

ICD-10 Finland

Low back pain

1.2

6.7

1336

11758

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.5

6.7

185

1234

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.1

6.7

302

G04BD01

ATC

emepronium; systemic

3.2

6.7

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

6.7

323

2394

A11CC03

ATC

alfacalcidol; systemic

1.9

6.7

378

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

6.7

638

5203

M01AX17

ATC

nimesulide; oral

1.3

6.6

682

5608

CEC00

NOMESCO Finland

Recession of extraocular muscle

4.0

6.6

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

6.6

1870

16968

K08.80

ICD-10 Finland

Toothache NOS

1.4

6.6

327

2434

132

Kela drug reimbursment

Sarcoidosis

3.2

6.6

TK810

NOMESCO Finland

Hemofiltration

3.5

6.6

P03

ICPC

Feeling depressed

1.3

6.5

397

3048

G81.1

ICD-10 Finland

Spastic hemiplegia

8.7

6.5

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.4

6.5

245

1738

181

Kela drug reimbursment

Retigabine and vigabatrin

10.0

6.5

J45

ICD-10 Finland

Asthma

1.4

6.5

355

2683

D06

ICPC

Abdominal pain localized other

1.4

6.5

318

2363

G41.9

ICD-10 Finland

Status epilepticus, unspecified

3.6

6.5

N17

ICPC

Vertigo/dizziness

1.3

6.5

413

3195

H05.2

ICD-10 Finland

Exophthalmic conditions

6.2

6.5

J20

ICD-10 Finland

Acute bronchitis

1.4

6.4

346

2608

M81.2

ICD-10 Finland

Osteoporosis of disuse

70.0

6.4

AEA30

NOMESCO Finland

Replacement of implanted pump of injection device in the nervous system

70.0

6.4

NEK20

NOMESCO Finland

Fenestration or forage of bone of pelvis

14.3

6.4

H43.9

ICD-10 Finland

Disorder of vitreous body, unspecified

2.6

6.4

130

N06AB06

ATC

sertraline; oral

1.3

6.4

403

3114

L95

ICPC

Osteoporosis

1.7

6.4

106

626

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.0

6.3

302

C08CA13

ATC

lercanidipine; oral

1.3

6.3

397

3063

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.3

6.3

185

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

3.6

6.3

U28

ICPC

Limited function/disability (U)

2.7

6.3

125

RF311, ,

NOMESCO Finland

11.0

6.3

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

3.5

6.3

WF099

NOMESCO Finland

Other radiotherapy

3.3

6.3

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.6

6.3

144

923

G37.3

ICD-10 Finland

Acute transverse myelitis in demyelinating disease of central nervous system

18.0

6.3

D33.37

ICD-10 Finland

Another benign tumor of the cranial nerves

18.0

6.3

PH4AC

NOMESCO Finland

Flebography head and neck area

+∞

6.2

J01XE01

ATC

nitrofurantoin; oral

2.1

6.2

270

2133

FHL

Suntin revisio

26.7

6.2

R03AC02

ATC

salbutamol; inhalant

1.2

6.2

2065

18952

H81.4

ICD-10 Finland

Vertigo of central origin

3.0

6.2

OAB43, ,

SPAT

0.8

6.2

982

11325

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

6.2

100

585

E000001, ,

ATC

1.2

6.2

671

5548

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

2.9

6.2

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

6.2

167

1110

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

6.2

439

3447

RS140, ,

NOMESCO Finland

4.0

6.2

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

6.1

336

2540

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.6

6.1

125

778

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

2.8

6.1

104

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.5

6.1

188

1283

G04BD10

ATC

darifenacin; oral

3.4

6.1

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.6

6.1

123

763

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

6.1

407

3167

D07AC01

ATC

betamethasone; topical

1.2

6.1

1237

10888

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.5

6.1

191

1310

H02.4

ICD-10 Finland

Ptosis of eyelid

1.8

6.1

477

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.5

6.1

190

1302

A12AA04

ATC

calcium carbonate; oral

2.2

6.1

220

JN4BD

NOMESCO Finland

Extensive body CT

1.4

6.1

275

2017

N76

ICPC

Neoplasm nervous system unspecified

12.5

6.1

P76

ICPC

Depressive disorder

1.4

6.1

250

1805

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

1.7

6.1

537

C09CA06

ATC

candesartan; oral

1.2

6.0

769

6470

H40

ICD-10 Finland

Glaucoma

2.6

6.0

122

SAA04

NOMESCO Finland

Special examination of mouth

1.5

6.0

173

1165

A03

ICPC

Fever

1.2

6.0

663

5491

D32.07

ICD-10 Finland

Secondary or multiple benign tumor of the meninges below the exam

10.0

6.0

G43.3

ICD-10 Finland

Complicated migraine

1.9

6.0

378

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

291

224

13.88

308.03

1.2

1.0

1.13

1.12

u/l

0.02

107

103

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

557

897

7.00

307.65

1.3

1.5

3.58

3.72

mmol/l

2.04

524

852

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

216

38.53

307.65

3.3

1.8

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

398

322

13.54

307.65

1.2

1.1

45.56

37.02

mg/l

1.13

325

273

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

558

882

7.14

307.65

1.5

1.7

485.94

5702.32

e6/l

0.64

434

682

(4027681) Cerebrospinal fluid IgG ratio and IgG index

320

246

13.99

307.65

1.3

1.2

0.76

0.59

ratio

4.04

164

154

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

549

870

7.11

307.65

1.4

1.6

17.13

33.94

e6/l

0.83

409

627

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

391

309

13.84

307.65

1.1

246.00

239.87

mg/l

0.08

340

274

(3044290) Cell count panel - Cerebral spinal fluid

534

816

7.35

307.65

1.4

1.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

382

296

14.09

307.65

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

649

1004

7.46

307.65

1.3

1.5

475.16

511.12

mg/l

0.48

619

959

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

179

103.81

307.65

1.2

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

361

96.20

307.65

1.3

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

338

389

9.36

272.11

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

407

619

7.17

258.57

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

922

3002

3.65

234.93

3.8

2.9

9.83

10.58

g/l

7.51

854

2798

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

483

1288

4.11

160.97

1.7

1.5

0.26

5.71

iu/ml

0.50

221

(3023410) Appearance of Cerebral spinal fluid

268

432

6.56

159.92

1.6

2.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

760

2738

3.17

159.89

2.7

2.4

22.75

19.39

au/ml

0.45

331

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

719

2527

3.22

157.56

1.4

1.3

84.89

49.78

au/ml

1.05

165

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

131

16.26

153.62

1.1

1.0

—

(3011412) CD3 cells [#/volume] in Blood

242

373

6.82

150.65

3.4

2.3

1359.73

1301.75

e6/l

0.36

205

317

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

208

279

7.79

146.78

3.5

2.5

237.47

214.15

e6/l

0.83

172

226

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

197

271

7.58

135.92

3.4

2.4

470.57

582.56

e6/l

1.57

157

209

(3000060) B lymphocytes [#/volume] in Blood

147

142

10.69

133.73

2.8

2.4

0.25

0.29

e9/l

0.10

(3006245) CD3-CD19+ cells/cells in Blood

160

178

9.30

131.34

3.5

2.5

5.61

11.20

4.73

151

168

(3001604) Monocytes [#/volume] in Blood

2768

19377

2.25

130.70

11.2

6.5

0.58

0.57

e9/l

1.79

2473

16734

(3006315) Basophils [#/volume] in Blood

2771

19415

2.25

130.43

11.2

6.5

0.04

e9/l

0.01

2471

16761

(3019198) Lymphocytes [#/volume] in Blood

2800

19857

2.22

125.57

11.3

6.6

1.82

1.96

e9/l

3.61

2540

17599

(3013115) Eosinophils [#/volume] in Blood

2806

20037

2.20

121.89

11.5

6.8

0.20

0.19

e9/l

0.81

2524

17611

(1175426) CD3 cells/Lymphocytes in Blood

197

306

6.70

121.52

3.0

2.2

75.02

72.98

0.89

191

294

(3019069) Monocytes/Leukocytes in Blood

2577

17826

2.15

121.23

11.5

6.8

8.86

8.65

3.30

2480

16809

(3006504) Eosinophils/Leukocytes in Blood

2560

17784

2.12

117.46

11.4

6.7

2.90

2.83

0.80

2466

16754

(3022096) Basophils/Leukocytes in Blood

2554

17781

2.11

115.78

11.6

6.8

0.69

0.68

0.63

2456

16740

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

482

1590

3.29

115.52

2.2

2.0

39.58

39.86

u/l

0.10

449

1445

(3013650) Neutrophils [#/volume] in Blood by Automated count

2939

21619

2.19

114.80

13.2

9.7

4.13

4.07

e9/l

0.67

2636

18768

(3018010) Neutrophils/Leukocytes in Blood

2577

18043

2.10

114.51

11.1

6.6

58.74

56.73

15.76

2508

17310

(3002030) Lymphocytes/Leukocytes in Blood

2606

18349

2.10

113.70

11.4

6.7

26.63

28.61

17.44

2523

17486

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

166

233

7.38

112.38

1.1

1710.64

1496.99

miu/ml

1.25

166

233

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

186

296

6.53

112.03

2.8

2.2

14.49

13.61

0.45

180

289

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

189

309

6.36

110.86

1.3

1.73

2.02

mmol/l

3.88

172

288

(3028026) IgM [Mass/volume] in Serum or Plasma

601

2358

2.81

105.67

3.1

1.9

1.06

1.38

g/l

6.78

573

2187

(3024561) Albumin [Mass/volume] in Serum or Plasma

2280

15868

1.95

95.73

5.9

5.1

36.17

36.07

g/l

0.39

2168

14944

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

169

301

5.81

90.74

3.1

2.2

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2803

21246

1.95

87.57

6.4

5.2

6.48

6.57

mmol/l

1.31

2683

19955

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

122

173

7.23

81.74

3.1

2.4

26.46

28.72

0.97

116

167

(3010503) CD19 cells [#/volume] in Blood

130

207

6.45

78.14

3.7

2.1

311.27

159.56

e6/l

0.37

130

201

(3002582) Erythrocytes [#/volume] in Urine

1756

11830

1.83

75.44

5.2

3.4

77.45

88.39

e6/l

0.12

1417

8980

(3000850) Epithelial cells [#/volume] in Urine

1316

8153

1.89

73.44

4.0

2.7

5.13

6.41

e6/l

3.78

1227

7410

(3018677) aPTT in Platelet poor plasma by Coagulation assay

968

5414

2.02

72.98

2.5

2.4

29.66

29.57

0.15

937

5265

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2331

17217

1.79

72.52

3.0

2.5

81.07

75.96

nmol/l

12.67

2183

15854

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

117

182

6.58

71.92

1.7

1.6

—

(3018095) Leukocytes [#/volume] in Urine

1968

13882

1.78

71.19

6.2

4.0

114.73

88.46

e6/l

0.45

1474

9582

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

116

182

6.53

70.71

1.4

1.3

64.62

71.13

0.23

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2376

17769

1.77

69.62

9.7

7.3

1.21

mmol/l

1.00

2085

15490

(36304419) Bacteria [Presence] in Urine

1504

9847

1.82

69.51

4.8

3.2

143.03

75.00

estimate

—

(3030467) Casts [#/volume] in Urine by Automated count

1547

10242

1.81

68.71

4.9

3.3

0.26

0.37

e6/l

1.73

1217

7474

(3015736) pH of Urine

2189

16086

1.75

67.27

4.8

3.4

6.29

6.23

1.44

1147

9103

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1591

10707

1.78

66.25

2.5

2.2

182.39

213.00

u/l

0.52

1516

10173

(3031040) Bacteria [#/volume] in Urine by Automated count

3011

24379

1.82

64.81

7.4

4.5

965.85

1705.90

e6/l

0.49

319

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3299

27493

1.92

64.62

9.9

8.1

80.19

78.32

u/l

0.94

3152

26198

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2461

18823

1.74

64.36

7.0

6.5

10.78

11.61

umol/l

2.34

2354

17946

(3026782) Osmolality of Urine

1137

6961

1.87

64.33

4.1

2.9

539.02

533.74

mosm/kgh2o

0.35

1034

6103

(3035350) Ketones [Presence] in Urine by Test strip

2584

20043

1.75

64.19

5.7

3.8

4.64

4.21

estimate

0.04

593

4202

(3009261) Glucose [Presence] in Urine by Test strip

2587

20158

1.73

62.34

5.8

3.8

0.01

0.09

estimate

0.54

577

3977

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2144

15885

1.71

62.01

9.2

6.9

1.21

mmol/l

1.90

2012

14773

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

286

993

3.02

61.82

2.1

10.98

11.41

mg/l

0.40

270

931

(3021601) Nitrite [Presence] in Urine by Test strip

2549

19833

1.72

61.21

5.7

3.8

0.00

estimate

0.72

578

4137

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

157

375

4.31

59.74

1.6

1.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

3089

25462

1.80

59.50

7.2

4.5

0.61

2.72

—

(3021589) Normoblasts [#/volume] in Blood

2236

16889

1.69

59.03

15.9

11.0

0.00

e9/l

0.18

1864

13719

(3032080) INR in Blood by Coagulation assay

2071

15467

1.67

55.92

14.4

13.5

1.21

1.22

inr

0.23

1715

12858

(3033658) Prothrombin time (PT) actual/Normal

1381

9327

1.71

54.15

5.3

4.3

93.48

91.22

2.98

1357

9126

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

154

6.08

52.61

1.2

1.1

73.55

199.60

ng/l

0.78

(21494814) CD8 cells/Lymphocytes in Specimen

134

6.45

51.57

2.7

1.9

26.88

29.99

1.10

134

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

151

396

3.92

50.64

3.8

2.6

19.57

20.07

nmol/l

0.18

146

380

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

8.63

49.45

1.1

1.3

—

(3002179) Metamyelocytes/Leukocytes in Blood

589

3141

2.02

48.92

5.4

4.4

0.75

0.67

0.17

193

903

(3017181) Myelocytes/Leukocytes in Blood

602

3303

1.96

45.90

5.7

4.6

0.91

0.87

0.13

204

965

(3021879) Hepatitis B virus core Ab [Presence] in Serum

612

3413

1.93

44.36

1.5

—

(3025159) Blasts/Leukocytes in Blood

583

3204

1.95

44.12

6.0

4.9

0.05

0.30

0.96

167

776

(3021440) Promyelocytes/Leukocytes in Blood

578

3171

1.95

43.96

5.8

4.7

0.11

0.02

180

831

(3018418) pH of Serum or Plasma

1475

10565

1.61

43.80

5.7

4.2

7.40

0.06

1085

7510

(3023511) Choriogonadotropin [Units/volume] in Urine

278

1146

2.53

42.96

1.6

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

669

3883

1.86

42.76

3.0

2.2

380.45

375.20

nmol/l

0.15

633

3609

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

984

6403

1.70

42.41

4.3

2.9

0.96

1.18

e6/l

0.88

545

3352

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

113

6.28

41.52

1.3

1.2

22.75

14.92

0.34

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3158

27189

1.64

41.05

5.4

4.4

12.10

11.12

mm/h

3.64

3000

25603

(3019550) Sodium [Moles/volume] in Serum or Plasma

3918

36058

2.22

39.45

24.1

17.0

139.62

139.63

mmol/l

0.17

3861

35370

(3023368) Bacteria identified in Blood by Culture

1326

9469

1.58

38.79

5.5

4.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3921

36144

2.21

38.52

24.3

17.1

3.94

3.95

mmol/l

1.82

3857

35382

(3009445) Proteinase 3 Ab [Units/volume] in Serum

326

1521

2.24

38.01

1.8

1.6

33.20

16.03

iu/ml

—

(3020630) Protein [Mass/volume] in Serum or Plasma

501

2760

1.93

37.29

2.2

2.7

66.62

66.70

g/l

0.09

472

2564

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

899

5899

1.67

36.84

4.4

3.1

3.18

2.85

e6/l

0.44

453

2839

(3017143) Hepatitis C virus Ab [Presence] in Serum

802

5110

1.70

36.72

1.7

1.6

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

290

1313

2.30

36.30

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1639

12441

1.52

35.64

3.2

3.4

2.35

mmol/l

0.54

1513

11420

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

130

5.38

34.89

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3914

36244

2.12

34.89

22.2

15.0

22.42

22.86

mg/l

0.36

3354

29647

(3003458) Phosphate [Moles/volume] in Serum or Plasma

755

4792

1.70

34.88

8.1

6.5

1.05

1.06

mmol/l

0.70

710

4475

(3011397) Hemoglobin [Presence] in Urine by Test strip

1273

9198

1.55

34.51

5.1

3.7

0.50

0.16

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

233

995

2.42

33.29

1.7

1.5

11.57

11.55

iu/ml

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

893

5983

1.62

33.27

4.1

3.8

0.82

mmol/l

0.63

857

5671

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

873

5844

1.62

32.55

2.1

1.9

—

(40758558) Short blood count panel - Blood

1498

11327

1.50

32.32

8.5

6.3

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

216

4.09

31.51

3.8

2.8

50.90

42.38

4.14

114

(3021447) Carbon dioxide [Partial pressure] in Venous blood

597

3673

1.73

30.58

6.2

4.4

5.76

5.80

kpa

0.49

590

3573

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1650

12862

1.46

29.90

4.1

3.6

38.99

58.16

ng/l

0.99

1132

8164

(3002032) Base excess in Venous blood by calculation

580

3579

1.72

29.31

6.3

4.5

1.41

1.73

mmol/l

1.13

498

3079

(3020779) Urea [Moles/volume] in Serum or Plasma

529

3191

1.75

28.97

10.3

8.2

9.07

9.18

mmol/l

0.13

508

3074

(3012544) pH of Venous blood

590

3704

1.69

27.89

6.4

4.4

7.37

7.38

2.01

378

2138

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

227

3.80

27.86

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

207

3.92

27.42

1.1

—

(3019977) pH of Arterial blood

615

3929

1.66

27.14

8.7

8.5

7.42

0.15

342

2119

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

615

3931

1.66

27.09

8.7

8.5

5.00

5.10

kpa

1.75

588

3787

(3027801) Oxygen [Partial pressure] in Arterial blood

615

3932

1.66

27.06

8.7

8.5

13.16

12.70

kpa

1.24

587

3788

(3037522) Nuclear Ab [Titer] in Serum

830

5708

1.57

27.01

1.5

1.4

409.03

525.00

titre

2.08

186

1175

(3029937) Albumin [Presence] in Urine by Test strip

1411

10847

1.45

26.69

6.4

3.9

0.00

estimate

1.94

544

3883

(3003396) Base excess in Arterial blood by calculation

608

3903

1.65

26.28

8.6

8.4

0.59

0.86

mmol/l

0.85

472

3205

(3014051) Protein [Presence] in Urine by Test strip

1434

11096

1.44

26.04

3.8

2.9

0.04

0.03

209

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

658

4320

1.62

25.97

2.1

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

629

4110

1.62

25.26

2.1

1.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1155

8622

1.47

25.16

1.9

1.5

2.09

2.28

g/l

4.26

769

5456

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

774

5315

1.56

25.16

3.3

2.7

21.81

23.06

1.72

729

4968

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1612

12807

1.42

25.03

4.1

3.3

32.39

33.78

u/l

0.26

1531

12146

(40760892) CBC W Ordered Manual Differential panel - Blood

1192

8962

1.46

24.99

8.0

4.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1042

7640

1.48

24.81

1.8

1.7

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4014

38093

2.12

24.47

26.7

18.6

75.71

74.29

umol/l

1.40

3982

37676

(3002173) Hemoglobin [Mass/volume] in Arterial blood

518

3266

1.67

23.87

9.3

9.2

120.85

121.87

g/l

0.52

500

3192

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3679

34076

1.63

23.81

19.8

14.1

86.22

85.15

ml/min/173m2

2.09

3432

31284

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1464

11533

1.41

23.44

3.2

2.7

57.74

66.23

u/l

0.62

1368

10743

(3024354) Oxygen [Partial pressure] in Venous blood

495

3105

1.67

23.23

5.6

3.9

4.85

4.65

kpa

1.40

490

3017

(3004789) Transferrin [Mass/volume] in Serum or Plasma

820

5795

1.52

23.15

3.2

2.6

2.32

2.36

g/l

1.23

771

5386

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

225

1105

2.09

22.93

1.5

1.3

—

(3000991) Gas panel - Venous blood

510

3239

1.65

22.80

11.8

9.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1892

15617

1.38

22.77

2.2

2.1

96.84

96.85

pmol/l

0.00

1053

8425

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

140

4.19

21.89

1.1

1.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

865

6273

1.48

21.31

3.2

2.6

12.50

13.57

umol/l

4.06

816

5883

(3007853) Bacteria identified in Skin by Aerobe culture

654

4478

1.55

21.21

2.1

1.7

—

(3008295) Osmolality of Serum or Plasma

111

415

2.72

20.93

1.5

285.96

280.33

mosm/kgh2o

1.79

310

(3017732) Neutrophils [#/volume] in Blood

690

4793

1.53

20.92

3.4

3.2

4.34

4.59

e9/l

0.72

618

4218

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

292

1629

1.85

20.57

2.8

1.9

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

154

681

2.31

20.37

1.6

1.7

0.61

0.72

g/l

0.68

122

540

(3021960) Folate [Moles/volume] in Serum or Plasma

1274

9984

1.40

20.35

1.8

1.7

19.50

20.29

nmol/l

0.87

1097

8594

(3016502) Oxygen saturation in Arterial blood

531

3499

1.59

20.31

9.2

8.9

96.37

95.78

2.13

508

3390

(3014111) Lactate [Moles/volume] in Serum or Plasma

495

3222

1.61

19.92

9.9

8.5

1.28

1.32

mmol/l

0.33

487

3164

(3035933) Granulocytes/Leukocytes in Blood

180

857

2.15

19.90

4.1

3.2

59.06

57.58

0.74

180

857

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3981

37940

1.88

19.82

17.0

11.5

26.38

25.73

u/l

1.17

3902

37007

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

591

4047

1.54

19.01

4.0

4.4

236.96

244.25

u/l

0.59

563

3857

(3045414) Leukocytes [Presence] in Urine

531

3563

1.56

18.70

2.6

2.1

0.05

0.01

estimate

0.63

104

767

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

142

632

2.29

18.53

1.3

341.18

384.71

titre

0.09

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3643

34042

1.52

18.51

6.2

5.5

1.83

1.85

mu/l

0.42

3439

31954

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1797

15033

1.34

18.46

5.9

3.7

0.21

0.07

estimate

0.33

512

3403

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1104

8567

1.39

18.33

2.1

1.9

1.31

1.15

mg/l

0.38

851

6565

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

142

637

2.27

18.19

1.3

125.71

224.00

titre

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

394

2478

1.65

18.15

5.5

4.5

5.20

5.13

kpa

0.85

377

2381

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

325

1946

1.73

18.00

10.3

11.3

16.24

16.01

0.77

308

1873

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

241

1320

1.88

17.98

2.0

1.8

1.19

1.18

g/l

0.20

232

1252

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1198

9452

1.37

17.89

3.3

3.2

1482.98

1283.02

ng/l

0.79

1010

8052

(3027945) Reticulocytes/Erythrocytes in Blood

586

4055

1.52

17.88

3.4

2.7

1.78

1.77

0.11

533

3653

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

260

1466

1.82

17.69

1.6

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

295

1729

1.76

17.62

2.1

1.9

7.56

6.74

iu/ml

0.16

420

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

345

2115

1.69

17.52

1.8

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

373

2336

1.65

17.46

2.8

2.3

5399.24

5799.82

u/l

0.08

106

944

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2861

25726

1.35

17.45

4.3

3.3

47.72

43.56

u/l

1.68

2736

24447

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

348

2144

1.68

17.34

5.5

4.5

1.50

1.63

mmol/l

0.27

250

1578

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1262

10082

1.36

17.29

2.6

2.4

2.94

2.71

mg/l

2.51

1123

8777

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

233

1279

1.87

17.27

2.1

1.8

0.23

g/l

0.44

223

1212

(3030981) Hyaline casts [#/volume] in Urine by Automated count

437

2854

1.59

17.24

4.0

2.5

0.39

0.42

e6/l

0.06

423

2712

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

223

1209

1.89

17.18

2.3

430.50

611.45

ug/l

0.37

210

1137

(3009343) pH of Capillary blood

381

2414

1.64

17.02

5.6

4.5

7.41

2.40

320

2002

(3010838) Calcium [Moles/time] in 24 hour Urine

141

649

2.21

17.00

1.9

2.0

4.98

5.06

mmol/24h

0.11

131

573

(3045424) Erythrocytes [Presence] in Urine

301

1809

1.71

16.44

2.9

2.1

0.00

0.44

estimate

0.52

592

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

213

3.13

16.29

2.0

1.8

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

117

3.96

16.26

1.2

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

457

3057

1.56

16.22

2.7

71.33

69.93

e9/l

0.37

329

2207

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3205

29448

1.37

16.18

5.2

4.6

14.77

14.61

pmol/l

3.29

3000

27376

(3008757) Leukocyte morphology finding [Identifier] in Blood

346

2.64

16.15

4.2

4.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

118

3.93

16.07

1.2

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

333

2073

1.66

15.93

10.7

24.03

24.25

mmol/l

0.62

328

2040

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

148

715

2.11

15.81

1.6

1.7

—

(3036489) Thrombin time

261

1525

1.76

15.76

2.7

2.6

20.84

21.13

0.44

239

1338

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

615

4406

1.46

15.68

3.1

2.9

7.11

7.39

umol/l

0.13

524

3854

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

163

820

2.03

15.63

7.3

6.0

797.57

691.22

iu/ml

0.10

108

(3021387) Prolactin [Units/volume] in Serum or Plasma

309

1898

1.68

15.56

2.3

1.7

333.74

294.69

mu/l

1.17

284

1715

(3004119) Hemoglobin [Mass/volume] in Venous blood

343

2166

1.64

15.51

5.5

3.6

129.24

129.78

g/l

0.17

332

2105

(3019309) Folate [Moles/volume] in Red Blood Cells

752

5602

1.42

15.50

1.8

1.7

1181.17

1164.85

nmol/l

0.21

587

4310

(46235355) HIV 1 and 2 tests - Meaningful Use set

1147

9166

1.35

15.32

2.0

2.1

—

(3042936) Bacteria identified in Isolate by Culture

699

5153

1.43

15.26

2.4

2.0

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

136

649

2.13

15.01

4.8

3.4

1638.20

1291.12

u/ml

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

222

1263

1.80

14.68

3.9

3.3

3.46

3.54

g/l

0.35

215

1200

(3024139) IgG subclass 3 [Mass/volume] in Serum

413

2.41

14.55

1.6

1.4

0.36

0.40

g/l

0.56

301

(3028192) IgG subclass 2 [Mass/volume] in Serum

413

2.41

14.55

1.6

1.4

2.70

2.90

g/l

0.51

303

(3027135) IgG subclass 1 [Mass/volume] in Serum

414

2.40

14.47

1.6

1.4

6.05

6.54

g/l

0.78

304

(4062490) Immunoglobulin typing, IgG

408

2.41

14.46

1.6

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

230

1330

1.77

14.40

5.7

5.5

0.87

0.88

0.22

214

1249

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

119

3.73

14.31

1.2

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

246

1453

1.74

14.31

5.5

5.2

1.54

1.62

0.87

229

1365

(3028626) Oxygen [Partial pressure] in Capillary blood

198

1100

1.84

14.16

6.5

5.0

8.78

8.64

kpa

0.54

192

1071

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

518

3664

1.47

14.02

3.3

2.5

34.16

50.97

u/l

0.69

437

3103

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

198

3.01

13.68

1.2

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.94

13.41

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

388

2611

1.54

13.34

1.9

1.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

111

3.72

13.33

1.2

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

404

2752

1.52

13.12

5.1

4.1

96.66

84.49

ng/l

1.14

356

2425

(3009214) Lutropin [Units/volume] in Serum or Plasma

236

1414

1.71

13.05

2.0

1.4

10.84

9.79

u/l

0.41

185

1122

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

105

3.74

12.79

1.2

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

492

3505

1.46

12.78

2.4

0.22

0.21

g/l

0.65

466

3290

(3041096) Erythrocytes [Presence] in Urine by Automated

1318

10965

1.29

12.71

5.2

3.2

0.50

0.12

estimate

0.36

510

3298

(40761536) Microorganisms panel - Urine sediment

439

3062

1.48

12.71

6.6

3.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

287

1824

1.62

12.64

1.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

850

6677

1.34

12.34

4.1

3.7

439.46

571.25

ng/l

0.29

586

4810

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

108

3.64

12.29

2.5

2.7

27.90

29.94

umol/l

0.42

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

252

1568

1.65

12.09

1.9

1.48

1.49

g/l

0.07

219

1372

(3052851) Hemolysis interference index of Serum or Plasma

176

992

1.81

12.05

3.0

3.1

2.24

2.14

index

0.08

518

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

343

2301

1.53

11.95

11.2

10.5

1.32

1.30

0.17

338

2287

(3008152) Bicarbonate [Moles/volume] in Arterial blood

308

2021

1.57

11.85

7.4

7.1

23.94

24.44

mmol/l

1.32

289

1929

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.37

11.81

1.9

1.7

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

8.93

11.72

1.1

1.0

1.84

7.30

u/l

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

5.25

11.52

1.3

1.2

62.00

45.73

—

(1616796) Gas panel - Central venous blood

143

766

1.90

11.52

4.4

3.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

110

538

2.07

11.47

2.3

2.5

28.61

37.81

iu/ml

—

(3044889) 12 lead EKG panel

2674

24399

1.26

11.46

4.1

3.8

0.80

9364.73

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

181

1045

1.76

11.44

5.0

4.3

0.35

0.36

iu/ml

0.04

567

(3022313) Gas panel - Capillary blood

271

1748

1.59

11.23

6.0

4.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

171

978

1.78

11.17

1.9

1.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

238

1490

1.63

11.15

4.5

3.5

24.65

25.21

mmol/l

1.56

229

1435

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

3312

31084

1.31

11.02

28.0

18.2

13.66

13.51

8.85

3281

30680

(3015171) Extractable nuclear Ab [Units/volume] in Serum

253

1617

1.60

10.90

1.3

2.06

0.64

u/ml

—

124

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

134

720

1.89

10.72

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

134

720

1.89

10.72

1.4

1.3

—

(3020891) Body temperature

243

1545

1.61

10.70

5.2

4.6

36.93

36.92

°c

0.29

238

1533

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

144

797

1.84

10.50

1.4

1.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

229

1442

1.62

10.50

6.7

5.0

24.67

24.64

mmol/l

0.06

211

1356

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

184

1101

1.70

10.28

2.9

2.7

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

170

2.84

10.20

2.9

2.5

60.61

51.73

umol/l

1.00

150

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

384

2723

1.45

10.18

5.7

3.8

1.22

1.23

mmol/l

1.05

345

2350

(3023183) Ammonium ion [Moles/volume] in Plasma

141

786

1.82

10.06

3.0

2.9

31.97

35.33

umol/l

1.00

125

724

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1116

9317

1.27

9.99

2.8

2.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

120

638

1.91

9.94

1.4

1.3

4.38

4.44

u/ml

0.01

294

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

203

1258

1.64

9.93

1.2

1.3

13.13

40.73

u/ml

—

(3021901) Oxygen saturation in Capillary blood

128

697

1.86

9.85

3.1

3.0

91.07

90.21

0.89

123

675

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

117

619

1.92

9.84

2.2

1.6

526.55

355.09

mu/l

0.37

100

496

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1981

17650

1.23

9.82

3.1

2.8

—

estimate

—

(3012516) Albumin [Mass/volume] in Urine

1260

10696

1.25

9.73

4.3

3.5

66.86

49.57

mg/l

1.46

824

6869

(3044640) Blood type and Crossmatch panel - Blood

1428

12294

1.24

9.73

2.9

2.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1276

10853

1.25

9.68

5.0

4.2

13.32

8.91

mg/mmol

1.78

834

6819

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

202

1260

1.63

9.64

2.2

2.5

2.99

2.90

g/l

0.58

187

1161

(3000494) Fungus identified in Specimen by Culture

593

4571

1.35

9.58

1.7

1.5

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

154

896

1.75

9.53

2.5

0.00

g/l

-0.00

145

851

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

273

1835

1.52

9.44

5.3

3.4

0.62

0.01

273

1825

(3027315) Oxygen [Partial pressure] in Blood

128

709

1.83

9.35

5.2

4.1

8.73

8.69

kpa

0.08

123

699

(3012501) Base excess in Blood by calculation

128

709

1.83

9.35

5.2

4.1

2.26

2.57

mmol/l

0.57

463

(3013290) Carbon dioxide [Partial pressure] in Blood

128

710

1.83

9.31

5.2

4.1

4.98

5.03

kpa

0.42

123

701

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

210

1335

1.60

9.29

2.2

2.5

3.53

3.72

g/l

1.21

195

1236

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.69

9.28

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

210

1336

1.60

9.26

2.2

2.5

4.20

4.23

g/l

0.25

194

1236

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

210

1336

1.60

9.26

2.2

2.5

7.46

7.29

g/l

0.71

194

1236

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

160

950

1.71

9.23

1.2

1.3

1.14

3.32

u/ml

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

160

953

1.71

9.12

2.4

0.00

g/l

-0.00

145

852

(3015235) Bicarbonate [Moles/volume] in Capillary blood

193

1208

1.63

9.10

3.2

3.1

24.09

24.68

mmol/l

1.23

188

1189

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.78

9.05

2.4

4.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2169

19604

1.22

9.03

3.7

3.3

113.50

102.43

ug/l

1.74

2044

18509

(3026493) Urate [Moles/volume] in Serum or Plasma

1107

9330

1.25

8.97

2.9

2.7

332.39

331.24

umol/l

0.13

988

8326

(3039000) Anion gap in Blood by calculation

119

656

1.84

8.85

7.1

7.6

11.97

11.35

mmol/l

0.83

104

582

(3018572) Chloride [Moles/volume] in Blood

119

657

1.83

8.81

7.1

7.6

104.88

105.34

mmol/l

0.34

104

583

(3009508) Creatinine [Moles/volume] in Urine

1390

12033

1.23

8.78

4.3

3.5

7.38

7.63

mmol/l

1.24

1201

10347

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

186

1166

1.62

8.73

2.3

2.5

0.22

1.00

g/l

5.95

168

1021

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

146

2.83

8.68

1.5

1070.77

411.23

mu/l

0.55

141

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

4.25

8.65

1.2

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

846

6939

1.27

8.58

2.8

2.9

2.44

mmol/l

0.03

756

6230

(3028679) Herpes simplex virus Ab [Presence] in Serum

274

2.28

8.43

1.1

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

116

647

1.82

8.33

1.4

1.3

4.38

4.04

u/ml

0.08

244

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

150

2.75

8.27

1.5

76.51

73.10

1.29

145

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

4.09

8.25

1.2

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

170

1059

1.63

8.20

3.7

3.5

32.94

69.19

mg/l

1.65

144

911

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

182

1153

1.60

8.20

2.2

2.5

9.63

10.43

g/l

1.80

164

1045

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

162

997

1.65

8.20

2.4

0.01

0.02

g/l

0.37

151

912

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

140

831

1.71

8.13

1.7

1.5

144.15

146.57

au/ml

0.08

246

(3034860) Kappa light chains.free [Mass/volume] in Serum

169

1060

1.62

7.95

3.7

3.5

65.19

55.90

mg/l

0.15

142

913

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

358

2626

1.40

7.86

3.3

3.5

4.50

4.53

pmol/l

0.14

329

2370

(3028433) Virus identified in Specimen by Culture

121

2.91

7.84

1.1

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

166

1041

1.62

7.82

1.4

1.3

—

(3010813) Leukocytes [#/volume] in Blood

4050

39588

1.59

7.79

34.3

22.8

6.87

6.75

e9/l

2.29

3980

38770

(3019150) Specific gravity of Urine by Refractometry

1041

8835

1.24

7.74

5.8

3.9

1.02

1.36

kg/l

0.80

723

5859

(3035941) MCH [Entitic mass]

4049

39581

1.58

7.72

34.1

22.7

30.19

30.20

0.08

4019

39231

(3024731) MCV [Entitic mean volume] in Red Blood Cells

4049

39581

1.58

7.72

34.1

22.7

90.88

90.64

2.73

4019

39233

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

4049

39584

1.58

7.68

35.1

23.2

40.14

40.70

1.87

4017

39214

(3007461) Platelets [#/volume] in Blood

4048

39574

1.57

7.66

34.3

22.8

258.89

256.69

e9/l

1.32

3992

38860

(3026361) Erythrocytes [#/volume] in Blood

4049

39586

1.58

7.66

34.2

22.7

4.47

4.50

e12/l

3.15

3985

38774

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

495

3836

1.33

7.65

8.2

6.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

452

3457

1.34

7.64

3.8

3.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

4049

39596

1.57

7.52

34.5

22.9

133.81

134.85

g/l

4.92

4018

39251

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

481

1.89

7.44

1.8

1.7

—

(3051611) Lipemic interference index of Serum or Plasma

336

2.07

7.42

3.2

20.50

13.75

index

1.34

204

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

181

1178

1.56

7.31

1.2

1.3

7.99

8.64

u/ml

0.04

171

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

180

1177

1.55

7.13

1.2

1.3

2.23

5.93

u/ml

0.66

105

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

20.04

7.13

1.3

1.0

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

211

2.34

7.13

2.4

2.1

1.98

1.85

umol/l

0.35

191

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

147

917

1.62

7.10

1.3

259.50

255.27

u/ml

0.07

103

547

(3047181) Lactate [Moles/volume] in Blood

156

988

1.60

7.09

6.1

6.2

1.38

1.28

mmol/l

0.38

135

860

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

145

902

1.63

7.09

1.6

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

197

1316

1.52

7.08

2.1

1.9

1.40

2.10

ug/l

0.73

170

1173

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

183

1204

1.54

7.05

6.7

5.6

1.54

1.43

mg/l

0.82

166

1121

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

151

957

1.60

6.85

1.7

1.6

—

(3003181) Sodium [Moles/volume] in Urine

108

629

1.74

6.77

1.9

1.4

64.00

63.00

mmol/l

0.08

514

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.26

6.74

1.5

1.31

1.45

mg/l

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

469

1.85

6.71

7.9

6.9

11.40

11.65

mg/l

0.22

441

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

212

2.28

6.61

1.3

1.1

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

7.80

6.60

1.1

1.3

20.13

43.92

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3451

33071

1.24

6.57

6.6

5.8

39.13

38.51

mmol/mol

3.36

3262

31231

(3042631) Mycobacterium sp identified in Specimen

416

1.89

6.53

4.7

2.9

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

285

2.09

6.53

1.3

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

154

995

1.57

6.46

1.8

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

208

2.27

6.45

1.3

146.47

131.76

nmol/l

0.76

208

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

341

1.98

6.44

1.3

1.1

—

(4268621) Lupus anticoagulant assay

462

1.83

6.40

2.5

2.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

342

1.97

6.39

1.3

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.74

6.35

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

329

1.99

6.35

1.3

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.58

6.30

1.2

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.90

6.30

1.6

2.1

20.13

16.04

umol/l

0.89

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

147

947

1.57

6.26

3.7

3.3

5.00

3.50

ratio

0.17

551

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

331

1.98

6.25

1.3

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3527

33928

1.24

6.19

5.2

4.7

5.87

5.82

mmol/l

1.18

3278

31539

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

353

1.94

6.19

1.3

1.1

—

(3037121) Protein [Mass/volume] in Urine

184

1249

1.49

6.17

4.1

3.7

602.51

355.59

mg/l

0.41

571

(3017446) Testosterone [Moles/volume] in Serum or Plasma

358

2731

1.34

6.17

3.1

2.3

11.72

12.38

nmol/l

0.75

324

2475

(3048929) Epstein Barr virus Ab [Presence] in Serum

223

1572

1.44

6.17

1.3

—

(3018333) Ribosomal P Ab [Presence] in Serum

320

1.98

6.11

1.3

1.1

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.11

6.08

1.5

1.83

1.88

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.11

6.08

1.5

0.56

0.89

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.11

6.08

1.5

1.46

3.29

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.11

6.08

1.5

0.63

1.90

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.11

6.08

1.5

1.50

2.09

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.11

6.08

1.5

3.58

2.05

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.11

6.08

1.5

2.75

3.30

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.11

6.08

1.5

1.38

1.08

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.11

6.08

1.5

3.46

5.07

mg/l

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

855

7270

1.22

6.07

1.8

1.7

19193756.10

30614992.31

pmol/l

0.35

719

6167

(40759836) Histone Ab [Presence] in Serum by Immunoblot

343

1.94

6.00

1.3

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

532

1.75

5.96

5.2

5.8

407.52

368.18

umol/l

1.56

471

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

406

3179

1.31

5.83

1.3

1.2

155.19

150.90

u/ml

0.07

148

1179

(43055514) Macroprolactin [Presence] in Serum or Plasma

119

2.62

5.79

1.5

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

348

2669

1.33

5.79

2.4

2.3

5.64

7.08

ug/l

1.25

301

2370

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1129

9905

1.19

5.71

1.4

1.80

1.57

u/ml

0.26

297

2726

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.91

5.71

1.5

1.3

1.80

1.55

iu/ml

—

(21494755) Public health laboratory ask at order entry panel

306

4004

0.75

5.68

1.3

—

(4146454) Self-monitoring of blood glucose

329

1.93

5.67

3.1

2.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

192

1343

1.45

5.57

2.1

2.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

5.01

5.55

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

165

1121

1.49

5.55

1.3

60.00

92.57

titre

1.99

105

(3004616) Nuclear Ab [Presence] in Serum

492

1.74

5.52

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.63

5.47

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

472

1.75

5.44

1.9

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

177

1225

1.46

5.43

2.0

1.9

—

(40768446) Kidney Pathology biopsy report

154

2.35

5.39

2.1

1.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

145

967

1.52

5.34

1.3

1.2

43.34

41.93

u/ml

0.04

(4035726) Immunohistochemistry procedure

383

3013

1.30

5.32

1.6

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

374

4719

0.77

5.32

1.9

3.35

3.44

ratio

0.87

281

3519

(40768443) Skin Pathology biopsy report

220

1593

1.40

5.29

1.3

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

870

7503

1.20

5.27

1.3

25.84

28.32

iu/ml

0.24

203

2231

(3016650) Hepatitis A virus Ab [Presence] in Serum

109

684

1.61

5.24

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

127

827

1.55

5.22

2.7

2.2

127.85

129.53

g/l

0.34

102

653

(3000330) Specific gravity of Urine by Test strip

239

1759

1.38

5.22

4.1

3.2

1.02

ratio

0.26

214

1563

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

114

2.55

5.20

1.1

1.3

108.71

125.57

nmol/l

0.33

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.65

5.20

1.3

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

159

1090

1.48

5.14

1.4

290.16

290.70

ug/g

0.01

605

(3048689) Calprotectin [Mass/mass] in Stool

654

5501

1.22

5.11

2.5

138.71

117.98

ug/g

0.57

527

4423

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

118

760

1.57

5.10

1.6

1.4

21.43

24.28

u/l

0.48

101

630

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.01

5.09

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

103

643

1.62

5.07

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

6.33

5.07

2.1

3.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

559

1.66

5.04

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

104

652

1.61

5.04

2.0

1.7

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.41

5.02

1.2

1.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

173

1212

1.45

5.01

1.2

1.1

4.05

4.09

0.02

166

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

273

1.95

5.01

1.8

1.6

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

396

1.78

4.96

1.3

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

4.34

4.92

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.49

4.89

1.3

1.0

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

7.71

4.84

1.1

1.3

1.60

0.63

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

355

1.82

4.84

1.2

60.07

66.13

u/l

0.30

323

(4024509) Urine culture

228

1690

1.37

4.79

2.4

1.9

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

176

2.17

4.77

2.1

2.8

213.13

163.07

umol/l

0.16

102

(3016038) Potassium [Moles/volume] in Urine

237

1.99

4.73

1.6

1.3

39.40

35.57

mmol/l

0.42

217

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

415

1.72

4.53

1.7

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

10.02

4.52

5.8

5.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

194

2.07

4.49

1.2

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

127

859

1.49

4.44

1.6

1.4

—

(3019225) pH of Specimen

397

3214

1.26

4.41

4.8

4.1

7.34

7.35

0.10

299

2335

(40768804) Tissue Pathology biopsy report

1637

15022

1.15

4.40

2.3

2.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

113

747

1.53

4.40

4.6

2.4

0.92

0.87

nmol/l

0.33

643

(1761868) Lipid panel - Serum or Plasma

1362

14954

0.87

4.36

3.1

2.9

—

(3005322) IgE [Units/volume] in Serum or Plasma

360

2885

1.27

4.35

1.5

1.3

343.92

222.00

u/ml

0.69

330

2694

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

110

727

1.53

4.30

1.5

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

325

1.80

4.29

1.3

1.2

116.57

111.26

pmol/l

0.30

325

(3049717) Cytology report of Urine Cyto stain

156

1110

1.42

4.21

2.2

2.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.34

4.04

9.4

11.1

5.38

5.83

mmol/l

0.30

(36660697) Celiac disease serology panel - Serum

420

3458

1.24

4.03

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

310

1.78

4.01

1.3

1.2

40.00

202.50

titre

—

(3020876) Protein [Mass/time] in 24 hour Urine

415

1.67

4.01

2.8

2.3

1.40

1.36

g/24h

0.04

242

(3001019) Free T4 and TSH panel - Serum or Plasma

170

2300

0.73

3.99

1.9

1.7

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

351

2837

1.26

3.97

2.5

2.7

68.74

70.47

ml/min/173m2

0.29

147

1176

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

105

700

1.51

3.97

1.7

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

581

1.56

3.94

1.3

1.2

—

(3042733) HLA Ab [Presence] in Serum

131

2.22

3.92

5.9

4.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.72

3.91

1.8

—

(4195642) Thrombophilia screening test

608

1.54

3.86

1.1

1.2

—

(3017704) Immunofixation for Urine

172

2.04

3.84

1.3

1.7

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

5.27

3.82

2.0

4.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

139

2.17

3.82

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

270

2129

1.29

3.75

1.2

1.1

65.83

126.56

titre

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

339

2749

1.25

3.74

1.5

1.4

—

(3000012) Reticulocyte production index

440

1.62

3.70

2.1

2.0

1.04

0.88

1.56

292

(3023419) Bacteria identified in Sputum by Culture

448

1.62

3.69

3.4

2.8

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

128

2.20

3.69

3.0

2.6

0.60

0.62

mmol/l

0.35

128

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

217

1.90

3.67

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.54

3.62

1.4

1.1

—

(44790048) Parainfluenza type 2 nucleic acid detection

499

1.57

3.58

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

499

1.57

3.58

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

499

1.57

3.58

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

499

1.57

3.58

1.5

—

(3011985) Renin [Units/volume] in Plasma

509

1.56

3.52

1.6

1.5

100.45

62.34

mu/l

0.37

461

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

144

2.09

3.52

1.6

1.3

83.87

88.14

0.24

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

286

3537

0.79

3.47

1.6

3.41

3.46

mmol/l

0.38

200

2363

(3040151) Glucose [Moles/volume] in Capillary blood

386

1.64

3.46

4.4

4.9

6.87

7.09

mmol/l

0.24

326

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

258

1.79

3.46

1.8

2.7

99.13

98.54

0.04

244

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

449

1.59

3.44

1.3

0.18

0.21

nmol/l

0.45

354

(1761482) Bacteria [#/volume] in Urine by Culture

107

740

1.46

3.43

5.9

4.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

230

2913

0.78

3.41

1.5

1.6

1001.73

994.97

mu/l

0.04

195

2438

(3022145) Colonoscopy Study observation

487

4143

1.20

3.39

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1618

15023

1.12

3.37

1.9

1.39

1.36

mmol/l

0.81

1365

12919

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.43

3.30

1.3

1.57

0.27

iu/ml

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

211

1.86

3.30

1.7

1.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

148

2.03

3.30

1.5

1.1

89.13

89.07

0.00

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

664

1.47

3.29

1.2

1.1

56.89

897.83

iu/ml

0.53

154

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

205

1.86

3.25

1.2

29.97

24.05

u/l

0.33

177

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

146

1082

1.36

3.18

1.9

45.21

41.41

nmol/l

0.89

141

1052

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

145

2.01

3.09

1.1

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

231

1.78

3.07

1.3

1.6

6.60

6.37

u/l

0.05

202

(40768797) Stomach Pathology biopsy report

585

5102

1.17

3.05

1.3

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

466

5415

0.84

3.03

1.5

1.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

175

1.89

2.99

1.3

1.4

136.88

158.21

mmol/24h

1.08

175

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

212

1.80

2.95

1.2

99.43

85.88

u/l

0.36

185

(3019420) Tryptase [Mass/volume] in Serum or Plasma

250

1.73

2.91

1.2

1.6

7.58

8.34

ug/l

0.17

221

(3037756) Immunofixation for Serum or Plasma

657

1.44

2.90

1.5

1.7

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

226

0.35

2.90

1.0

1.2

6.50

8.76

mm/h

—

226

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

179

1.85

2.81

1.5

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1290

0.71

2.78

1.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.92

2.77

1.1

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

277

1.67

2.76

1.3

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

202

1.79

2.76

1.8

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

936

8497

1.13

2.75

5.3

3.55

2.72

ug/l

0.32

841

7680

(3024891) Influenza virus A+B Ag [Presence] in Specimen

149

1136

1.32

2.74

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

340

1.60

2.73

1.4

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

182

1.82

2.68

1.5

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

227

1.72

2.66

1.8

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

141

1072

1.33

2.65

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

329

2770

1.20

2.61

1.7

1.4

23.96

24.86

iu/l

0.19

278

2345

(3005033) Fetal Nuchal fold Thickness US

1272

0.72

2.59

1.4

1.5

1.34

1.25

0.77

911

(3025549) Creatine [Moles/time] in 24 hour Urine

3.61

2.57

1.7

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1323

0.73

2.51

1.5

1.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

117

1550

0.75

2.50

1.4

1.5

1.13

1.16

ratio

0.13

924

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

793

0.65

2.48

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

150

1164

1.30

2.46

2.2

2.1

4.31

8.46

iu/l

0.41

493

(3026389) Candida sp identified in Specimen by Organism specific culture

562

1.43

2.46

1.5

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

128

1669

0.76

2.45

1.5

60.01

60.09

ug/l

0.01

107

1396

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

115

860

1.35

2.44

1.7

1.5

0.42

nmol/l

0.02

680

(3022621) pH of Urine by Test strip

355

3030

1.19

2.43

2.9

2.5

6.05

6.12

0.61

228

1980

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

118

1553

0.75

2.42

1.4

1.5

1.22

1.18

ratio

0.18

933

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

118

1553

0.75

2.42

1.4

1.5

1.04

0.94

ratio

1.04

927

(42529406) Shigella sp [Presence] in Stool by Culture

141

1088

1.31

2.42

1.2

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

384

1.52

2.40

1.7

1.6

58.83

58.69

0.01

241

(3014765) Yersinia sp identified in Stool by Organism specific culture

140

1082

1.30

2.38

1.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

6.26

2.37

2.6

1.8

1.30

2.14

mu/l

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

205

1.71

2.37

1.6

1.5

1.23

1.28

nmol/l

0.10

150

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

117

1535

0.76

2.36

1.4

1.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.12

2.36

1.7

4.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

721

1.37

2.33

2.8

2.5

176.08

102.90

ug/min

0.52

446

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

253

1.63

2.30

1.2

1.08

1.05

ratio

1.01

205

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.07

2.26

1.0

1.2

—

24.00

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

206

1682

1.24

2.25

1.3

175.68

219.96

miu/ml

1.04

831

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.28

2.24

3.0

2.7

4.53

57.32

ug/l

0.50

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

107

1.97

2.20

2.2

3.2

161.46

142.35

ng/l

0.17

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

376

1.50

2.20

1.6

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

150

1.81

2.19

5.1

3.5

1.02

1.16

0.18

150

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

626

0.64

2.19

3.3

4.1

74.05

30.54

u/ml

0.70

610

(3003329) Lymphocytes/Leukocytes in Synovial fluid

296

1.56

2.19

1.7

1.5

29.43

32.67

0.21

180

(3020911) Cortisol [Moles/time] in 24 hour Urine

143

1.82

2.18

1.3

1.5

241.00

323.71

nmol/24h

0.12

143

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

136

1.84

2.17

9.3

4.7

—

(3008898) HLA-B27 [Presence]

199

1627

1.23

2.16

1.0

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

196

1.69

2.15

1.2

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

196

1.69

2.15

1.2

1.8

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.69

2.15

2.0

1.3

—

(3025941) Bacteria identified in Stool by Culture

262

2207

1.20

2.11

1.4

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

170

1372

1.25

2.08

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.91

2.07

1.3

1.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

135

1062

1.28

2.05

1.4

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1232

0.75

2.05

1.8

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

482

1.42

2.04

1.3

1.4

251.58

338.26

pmol/l

2.30

420

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

759

6925

1.12

2.04

1.3

6.83

9.66

u/ml

0.88

271

2782

(21494890) Protein electrophoresis panel - 24 hour Urine

326

1.51

2.03

2.2

2.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

2.40

2.02

3.3

3.6

31.58

46.04

umol/l

1.82

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

120

933

1.29

2.00

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

153

1895

0.80

1.99

1.5

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

377

1.46

1.98

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.34

1.96

2.6

2.9

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

107

822

1.31

1.96

1.1

22.41

17.15

au/ml

0.18

196

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

105

1.91

1.95

1.8

1.3

100.05

103.91

0.22

100

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

210

1.62

1.94

1.5

1.6

5.61

5.24

u/l

0.08

176

(3013336) Amino acids [Identifier] in Serum or Plasma

2.97

1.93

7.6

3.4

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

2.73

1.93

1.0

0.01

0.30

u/ml

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

135

1.78

1.91

1.0

1.1

—

6.80

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

421

0.59

1.89

1.3

1.6

7.36

7.67

mmol/l

0.52

405

(3001964) Herpes simplex virus Ag [Presence] in Specimen

107

1.87

1.86

2.4

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

569

1.36

1.84

1.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

254

1.54

1.81

1.1

1.74

5.15

nmol/l

—

(3044927) Protein electrophoresis panel - Urine

311

1.48

1.80

1.3

1.2

—

(4198724) Urine methamphetamine measurement

200

1.60

1.77

1.2

3.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.50

1.74

2.3

4.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

315

1.47

1.70

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

210

1.58

1.70

1.5

1.6

5.17

5.38

nmol/l

0.02

161

(3024932) HLA-DR beta [Type]

118

1.78

1.70

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

133

1.73

1.69

2.0

1.8

39.78

40.52

g/l

0.23

133

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

501

1.36

1.69

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

126

1.75

1.67

1.6

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

126

1.75

1.67

1.6

1.4

—

(4038314) Semen analysis, post vasectomy

3.16

1.66

1.3

1.2

—

(3034426) Prothrombin time (PT)

134

1.72

1.65

1.4

1.3

26.70

29.16

1.86

134

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

598

1.33

1.65

1.2

28.55

37.72

u/l

0.51

516

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.80

1.65

3.6

5.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.44

1.64

1.1

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

704

1.30

1.63

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

2.25

1.63

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

135

1.71

1.62

1.0

1.1

—

(3024471) HLA-A [Type]

120

1.75

1.62

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

3.57

1.61

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1063

0.77

1.61

1.5

57.66

59.20

ug/l

0.10

1063

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.15

1.61

1.1

0.29

0.84

u/ml

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

285

2483

1.16

1.60

3.3

3.0

198.77

186.86

ng/l

0.17

260

2256

(3044242) Glucose [Moles/volume] in Arterial blood

198

1.57

1.59

2.0

2.1

7.66

8.24

mmol/l

0.33

198

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.00

1.58

5.3

4.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.00

1.58

1.0

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

397

1.39

1.56

2.5

2.2

23.75

21.39

mg/l

0.14

153

(3033099) Centromere Ab [Titer] in Serum

1.89

1.54

1.0

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

676

1.29

1.53

3.1

3.6

289.43

706.57

u/ml

0.46

629

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.34

1.52

6.8

5.9

563.60

407.60

umol/l

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

136

1648

0.82

1.51

1.1

1.53

1.54

g/l

0.17

136

1648

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3616

35628

1.10

1.49

5.7

5.3

2.69

2.74

mmol/l

3.53

3391

33564

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

111

1372

0.80

1.49

1.5

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

302

2664

1.14

1.45

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

110

1.73

1.42

3.8

3.2

9.75

10.43

kpa

0.47

110

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

110

1.73

1.42

3.8

3.2

4.59

4.85

kpa

0.49

110

(3011288) Drugs identified in Urine by Screen method Nominal

175

1482

1.19

1.42

2.5

3.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

189

1.54

1.39

1.0

1.1

—

(3017569) Oxygen content in Arterial blood

181

1.55

1.39

2.0

2.4

15.35

16.61

1.49

181

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.42

1.39

1.6

255.43

331.90

umol/24h

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.61

1.36

1.2

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

151

1.59

1.34

4.3

6.5

57.74

69.41

mg/l

0.50

109

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

690

1.27

1.34

1.8

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

131

1565

0.83

1.29

1.9

1.7

5.71

4.65

mg/l

0.31

1145

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.78

1.28

4.2

7.9

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

243

1.44

1.27

1.4

70.60

79.42

umol/l

1.87

243

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

443

4039

1.11

1.26

5.0

4.6

31.67

32.34

0.70

326

2782

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

790

7400

1.08

1.25

1.5

—

(40768795) Lymph node Pathology biopsy report

346

1.36

1.24

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

433

1.32

1.23

1.2

1.1

—

(4211845) Urine protein measurement

171

1.52

1.23

3.5

3.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

725

6772

1.09

1.23

4.6

4.4

22.58

21.64

0.87

343

3191

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.04

1.22

1.5

2.1

—

(3044009) aPTT.lupus sensitive (LA screen)

2.16

1.21

1.3

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

801

1.23

1.19

2.1

1.9

182.47

202.68

pmol/l

1.10

753

(3028707) Methadone [Presence] in Urine by Screen method

108

892

1.22

1.19

2.3

3.0

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

281

1.39

1.18

2.0

1.5

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.88

1.18

2.9

2.0

1.16

1.20

umol/l

0.16

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

324

1.36

1.17

3.1

2.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

198

1729

1.15

1.6

1.7

0.38

0.30

mg/l

0.67

789

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

536

1.27

1.14

1.1

1.50

1.49

g/l

0.07

490

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.69

1.13

1.3

1.2

4.51

9.74

pmol/l

—

(4212803) Bone marrow aspirate examination

2.26

1.10

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

260

1.39

1.09

1.7

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3568

35238

1.08

5.1

4.8

4.59

4.66

mmol/l

4.30

3362

33336

(3020191) Ethanol [Moles/volume] in Serum or Plasma

304

1.35

1.07

1.5

1.09

1.22

promille

0.23

242

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

134

1564

0.85

1.06

1.0

1.1

0.56

0.64

ratio

0.75

179

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.12

1.05

1.7

3.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

288

0.66

1.03

1.0

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

341

1.32

1.03

1.3

1.81

3.12

u/ml

0.66

190

(3003327) Ova and parasites identified in Stool by Light microscopy

177

1549

1.15

1.02

1.7

—

(3006462) Nitrate [Presence] in Urine

155

1.49

1.01

3.8

3.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.00

1.00

1.4

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

317

1.33

0.99

4.8

3.9

—

(3042517) Benzodiazepines panel - Urine

1.84

0.98

1.6

2.1

—

(3020393) Adenovirus Ag [Presence] in Stool

1.81

0.98

1.7

1.8

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.85

0.96

1.8

1.4

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

207

1.40

0.96

3.3

2.0

24.97

29.04

umol/l

2.08

191

(3019174) dRVVT (LA screen)

1.89

0.94

1.1

—

(3022670) pH of Venous cord blood

2.22

0.93

1.2

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

348

1.30

0.91

2.8

2.4

4.02

4.03

mmol/l

0.07

343

(3035285) Chloride [Moles/volume] in Venous blood

348

1.30

0.91

2.8

2.4

105.07

105.58

mmol/l

0.25

343

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.14

0.91

1.2

1.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.14

0.91

1.2

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

585

6224

0.93

0.90

2.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

111

1.53

0.87

1.1

1.3

0.45

1.05

u/ml

0.55

111

(3016750) Collection duration of Urine

186

1.40

0.87

2.8

2.3

511.14

499.80

min

0.38

138

(21494434) Karyotype in Bone marrow

307

1.31

0.87

1.1

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

178

1.41

0.86

1.2

1.3

297.80

370.55

u/l

0.34

163

(3041806) Other cells [#/volume] in Blood by Manual count

191

0.63

0.84

1.2

1.6

0.53

0.50

e9/l

0.23

191

(3001186) Copper [Moles/volume] in Serum or Plasma

129

1.48

0.83

2.1

1.3

18.28

16.92

umol/l

0.46

112

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

257

1.33

0.83

1.4

1.5

15.17

23.00

u/ml

—

(3044007) Cell count panel - Peritoneal fluid

114

0.53

0.82

5.2

2.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

225

0.67

0.81

1.9

2.0

0.39

3.51

u/ml

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.61

0.81

1.7

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

155

1.42

0.81

3.3

2.4

—

(3045142) Bone marrow Pathology biopsy report

400

1.25

0.80

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

102

877

1.17

0.80

1.6

1.7

7388.78

12754.53

e6/l

2.01

611

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.79

0.0

2.8

—

0.64

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

340

1.27

0.77

2.9

2.5

1.22

1.19

mmol/l

1.32

335

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

137

1210

1.14

0.75

3.1

3.6

46.17

3539.53

u/ml

0.91

114

1044

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.00

0.72

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.00

0.72

1.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

159

1.39

0.72

1.0

6.61

13.43

u/ml

1.44

108

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.92

0.70

1.0

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.71

0.70

1.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

583

5534

1.06

0.68

1.7

1.8

—

(3032057) Clostridioides difficile [Presence] in Stool

1.53

0.68

1.4

1.8

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

266

1.28

0.68

2.8

2.1

2.82

1.57

u/field

0.50

146

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.51

0.66

2.1

2.2

1.33

1.73

mmol/l

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

537

5659

0.94

0.66

2.1

2.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

755

0.85

0.65

2.1

2.3

5.01

7.20

umol/l

1.28

562

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

916

8819

1.05

0.65

1.8

1.7

—

(3025130) Human papilloma virus identified in Specimen

755

1.16

0.64

2.0

1.9

—

(3004775) Volume in Urine collected for unspecified duration

242

1.28

0.64

2.8

2.4

653.63

606.06

0.33

163

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

377

1.22

0.64

1.4

1.3

—

titre

—

(3047189) Immunofixation for 24 hour Urine

155

1.36

0.62

1.4

1.7

—

(3004451) EKG impression Narrative

190

1.32

0.62

1.0

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

351

1.23

0.62

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

270

1.26

0.62

1.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

466

4920

0.94

0.61

1.8

1.54

1.43

1.92

417

4361

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.48

0.60

1.0

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.5

—

538.20

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

0.49

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3535

35054

1.05

0.60

5.0

4.7

1.44

1.47

mmol/l

4.32

3314

32976

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

308

1.24

0.59

1.3

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

1.54

0.59

1.6

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2626

25884

1.04

0.58

3.5

3.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

141

1.35

0.56

2.0

1.8

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

141

1.35

0.56

2.1

1.8

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.57

0.56

1.0

1.1

—

(3002256) Pathology report gross observation

521

4966

1.06

0.56

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

351

0.80

0.54

1.1

19.12

15.24

u/ml

0.33

142

(3026470) Cobalt [Mass/volume] in Blood

169

1.30

0.53

3.0

2.3

3.88

3.28

ug/l

0.31

161

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

442

1.18

0.52

1.8

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

357

3373

1.06

0.52

3.8

4.3

30.60

27.18

ug/l

0.05

289

2673

(3024522) Salmonella sp identified in Specimen by Organism specific culture

443

1.18

0.51

1.8

1.4

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.50

0.51

1.8

—

(3020491) Glucose [Moles/volume] in Blood

269

1.23

0.51

1.6

1.9

6.67

6.47

mmol/l

0.15

196

(3035320) C reactive protein [Mass/volume] in Body fluid

306

1.21

0.50

2.9

2.5

27.15

28.82

mg/l

0.08

218

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.46

0.50

1.0

90.67

92.10

titre

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

279

1.22

0.50

1.4

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

188

1740

1.08

0.49

2.2

2.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

178

0.73

0.48

1.1

—

(3002619) Bacteria identified in Specimen by Culture

102

1.37

0.47

1.5

1.2

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

3166

31371

1.04

0.47

28.7

18.9

331.71

332.41

g/l

4.31

3151

31196

(3039443) Prostate specific Ag panel - Serum or Plasma

484

0.85

0.47

1.6

1.7

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.46

0.46

1.0

1.1

0.41

0.42

u/ml

—

(3017509) Phencyclidine [Presence] in Urine

1.46

0.46

1.4

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

255

0.78

0.46

16.7

15.1

716.45

5888.85

nmol/l

0.51

247

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

182

1.27

0.46

1.9

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

182

1.27

0.46

1.9

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

182

1.27

0.46

1.9

1.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

282

1.21

0.46

1.4

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.62

0.45

1.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

449

1.16

0.45

1.8

1.4

—

(4015189) Microbial culture of sputum

1.43

0.45

2.6

—

(40768793) Breast Pathology biopsy report

948

0.89

0.45

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.40

0.45

2.9

2.1

—

(3001556) Androgen free Index in Serum or Plasma

1.37

0.44

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.37

0.44

1.1

1.3

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

367

1.17

0.44

1.8

2.0

20.22

26.16

ug/l

0.52

361

(3007700) Barley IgE Ab [Units/volume] in Serum

1.61

0.43

1.0

1.1

—

1.62

u/ml

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.61

0.43

1.0

1.2

1.60

20.77

u/l

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.61

0.43

1.6

1.3

—

6.32

mmol/l

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

120

1098

1.10

0.43

1.1

1.20

5.61

eliau/ml

2.88

153

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

393

0.84

0.42

1.3

1.5

—

(44813793) Dust mix specific IgE antibody measurement

294

1.19

0.42

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

1.56

0.42

1.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

985

0.90

0.42

1.1

6.27

5.72

u/ml

0.09

566

(44806071) Cardiolipin IgM antibody measurement

1.38

0.41

1.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.41

0.0

1.2

—

3.33

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.86

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

342

1.17

0.40

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

141

1.28

0.40

2.1

1.8

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

0.03

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

148

0.74

0.38

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

317

1.17

0.37

1.2

1.1

16.75

1.80

u/ml

0.64

100

(3024263) Appearance of Synovial fluid

170

1.24

0.37

1.4

1.9

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

290

1.17

0.36

1.1

0.14

3.22

u/ml

0.92

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.36

0.36

2.5

1.4

—

0.33

—

(40758292) HTLV I+II Ab panel - Serum

0.64

0.35

1.0

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

736

1.10

0.35

1.6

1.8

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.62

0.35

1.0

2.8

1.23

1.19

mmol/l

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.36

0.34

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

243

0.82

0.33

1.4

1.3

—

(3013637) Mi-2 Ab [Presence] in Serum

100

1.30

0.33

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

100

1.30

0.33

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

100

1.30

0.33

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

100

1.30

0.33

1.0

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.30

0.33

1.8

2.1

1.02

1.36

mg/l

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

182

1.21

0.33

1.9

1.7

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

173

1.21

0.32

2.2

1.7

1.07

3.97

u/field

1.49

126

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

342

1.14

0.31

1.3

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

419

1.12

0.30

1.9

1.4

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

1.33

0.30

1.4

1.3

200.78

134.06

mg/l

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.25

0.29

2.9

2.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

230

2197

1.05

0.28

2.8

3.2

53.88

57.17

u/ml

0.05

223

2120

(3020874) Milk IgE Ab [Units/volume] in Serum

326

1.14

0.28

1.1

0.34

2.23

u/ml

1.32

127

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

421

1.12

0.28

1.9

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

298

1.14

0.28

1.5

2.9

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

523

5086

1.03

0.27

3.2

0.75

ug/l

0.04

341

3213

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

116

0.78

0.27

1.0

1.5

14.58

8.85

ug/l

—

116

(3005988) Vibrio sp identified in Specimen by Organism specific culture

423

1.11

0.27

1.9

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.21

0.26

1.6

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

113

1.24

0.26

2.6

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

215

1.16

0.26

1.0

870.26

740.45

ng/l

0.46

141

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.26

0.26

1.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

896

1.07

0.26

1.3

1.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

0.67

0.25

2.2

3.3

1.24

1.21

mmol/l

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

216

1.16

0.25

1.2

1.4

6.28

5.58

mmol/l

0.49

206

(3045788) Cell count panel - Pleural fluid

319

0.88

0.25

1.3

1.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

217

1.15

0.24

1.0

36.05

41.06

ng/l

0.32

143

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

812

1.07

0.24

1.4

2.35

3.78

ug/l

2.66

744

(3027944) Amphetamines [Presence] in Urine

198

2067

0.96

0.24

2.3

2.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

951

0.93

0.24

1.1

1.34

1.07

u/ml

0.11

453

(3036071) Salmonella sp Ab [Titer] in Serum

152

1.19

0.23

1.1

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

229

2380

0.96

0.23

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

209

1.15

0.22

1.0

1.4

160.80

203.66

pmol/l

0.43

209

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.25

0.22

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

163

1558

1.05

0.22

1.7

1.6

27.06

14.10

u/ml

0.64

395

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

178

0.84

0.22

2.1

1.9

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.1

—

(3036180) Methadone [Presence] in Urine

0.00

0.21

0.0

2.5

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

2.16

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3028300) Cannabinoids [Presence] in Urine

202

2100

0.96

0.21

2.3

2.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

173

1658

1.05

0.21

2.4

2.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

1.16

0.21

1.0

1.1

0.08

1.57

u/ml

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(40768800) Prostate Pathology biopsy report

522

0.92

0.20

1.1

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

166

0.84

0.20

1.1

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.22

0.20

1.0

1.1

0.02

u/ml

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

313

0.89

0.20

1.4

30410.28

88367.92

e6/l

0.80

210

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.18

0.19

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

333

0.90

0.19

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

171

1644

1.04

0.19

1.5

—

(3027008) Opiates [Presence] in Urine

202

2091

0.96

0.18

2.3

2.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

384

0.91

0.18

1.3

1.5

1133.91

4496.29

e6/l

0.82

265

(3027456) Digoxin [Moles/volume] in Serum or Plasma

561

1.07

0.17

4.4

3.4

0.75

0.82

nmol/l

1.07

455

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

329

1.10

0.17

1.0

296.47

291.81

mg/l

0.12

304

(3051387) C reactive protein [Mass/volume] in Capillary blood

737

1.06

0.17

3.6

3.5

30.58

26.23

mg/l

0.42

510

(3012441) Differential panel - Pleural fluid

320

1.09

0.17

1.2

1.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.16

0.16

1.1

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

158

1.14

0.16

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3342

33307

1.02

0.16

4.3

4.0

1.31

1.26

mmol/l

3.54

3121

31109

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

216

1.11

0.15

1.0

273.78

301.24

ng/l

0.29

146

(3014133) Dog dander IgE Ab [Units/volume] in Serum

800

1.05

0.15

1.1

5.10

4.15

u/ml

0.22

419

(3003434) Protein [Mass/volume] in Pleural fluid

410

1.07

0.15

1.3

1.5

30.21

32.54

g/l

0.64

369

(3038177) Helicobacter pylori Ab [Presence] in Serum

685

1.05

0.14

1.1

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

744

1.05

0.13

1.1

9.98

4.58

u/ml

0.80

348

(3028308) Erythrocytes [#/volume] in Pleural fluid

335

0.92

0.13

1.3

1.4

66391.31

84223.37

e6/l

0.13

189

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

238

1.09

0.13

4.1

7.1

9.44

93.17

ug/l

0.61

150

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

620

1.05

0.12

1.1

2.43

3.56

eliau/ml

0.58

301

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

114

1.14

0.11

1.0

1.2

0.49

15.64

u/ml

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

405

3987

1.02

0.11

2.1

—

(4034850) Laboratory test

113

1094

1.03

0.11

12.1

9.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

134

1.12

0.10

1.1

1.2

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.14

0.10

1.0

163.40

164.14

g/l

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.11

0.09

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.09

0.09

7.0

7.5

10.86

10.95

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

350

0.94

0.09

1.1

11.02

8.81

iu/ml

0.26

(3012494) Peanut IgE Ab [Units/volume] in Serum

155

1.10

0.09

1.1

1.2

0.77

27.61

u/ml

0.73

(3010726) Horse dander IgE Ab [Units/volume] in Serum

938

0.97

0.08

1.1

3.87

1.57

u/ml

0.70

506

(3000764) Benzodiazepines [Presence] in Urine

204

2078

0.98

0.08

2.2

—

(3014271) Vancomycin [Susceptibility]

136

1.10

0.08

3.6

2.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

623

0.96

0.08

1.4

1.3

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

1.09

0.08

1.0

1.1

0.23

2.72

u/ml

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.83

0.07

1.0

1.4

1.18

mmol/l

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.03

0.07

5.4

5.8

5.00

5.34

kpa

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

157

1.08

0.07

1.0

1.1

4.47

6.64

u/ml

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

218

2148

1.02

0.07

1.3

1.4

—

(40768441) Liver Pathology biopsy report

285

0.95

0.06

1.4

1.5

—

(3003694) ABO and Rh group [Type] in Blood

1169

11745

0.99

0.06

1.5

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

651

1.03

0.06

1.1

4.12

2.91

0.29

111

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

233

0.94

0.05

1.4

1.2

—

(44806420) Estimation of glomerular filtration rate

455

0.97

0.05

2.0

2.3

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

120

0.92

0.05

1.1

1.0

20.11

19.89

mmol/l

0.13

112

(40765096) Chromosome analysis panel by Banding

120

1.08

0.04

1.2

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

191

0.94

0.04

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

853

1.02

0.04

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

301

0.96

0.03

1.5

16.60

787.53

pmol/l

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

428

1.03

0.03

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

139

0.94

0.03

3.5

1.9

0.00

0.04

estimate

0.80

139

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

310

1.03

0.03

1.7

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

310

1.03

0.03

1.7

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

310

1.03

0.03

1.7

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

698

1.02

0.03

1.1

1.44

0.22

u/ml

0.61

242

(3016879) Cocaine [Presence] in Urine

196

1944

1.01

0.03

2.3

2.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

983

0.99

0.03

1.6

1.5

130.97

163.40

pmol/l

0.37

962

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

401

1.02

0.02

3.1

4.9

42.76

104.42

u/ml

—

129

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

325

3265

1.00

0.02

1.9

2.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

930

1.01

0.02

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

113

1.06

0.01

1.1

1.0

43.93

42.42

iu/ml

0.02

113

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

729

0.99

0.01

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

153

1539

0.99

0.01

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

852

1.01

0.01

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

112

1113

1.01

0.00

1.2

1.1

2.15

2.31

u/ml

0.09

625

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

126

0.95

0.00

1.8

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

154

1.04

0.00

2.4

3.2

—

(4281824) Cell count and differential, peritoneal fluid

404

1.01

0.00

1.2

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

102

0.98

0.00

1.0

1.1

0.46

3.58

u/ml

—

(3006598) pH of Arterial cord blood

105

1.05

0.00

1.1

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

106

1.04

0.00

2.8

1.7

—

(1002224) Polysomnography panel

191

1915

1.00

0.00

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

157

1.02

0.00

1.6

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

404

0.99

0.00

1.1

—

(40768806) Pleura Pathology biopsy report

313

0.99

0.00

1.3

1.6

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.99

0.00

1.1

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.03

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.0

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.99

0.00

1.1

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.91

0.00

1.0

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.99

0.00

1.1

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

1.87

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1296.00

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

5.8

—

0.24

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.01

-0.00

1.6

3.3

34.56

43.65

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

0.98

-0.00

1.2

1.8

26.57

36.33

pmol/l

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

1.01

-0.00

3.1

6.5

7.11

8.00

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(4133840) Spirometry

0.96

-0.00

1.0

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

670

1.00

-0.00

1.1

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.00

-0.00

1.1

1.2

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

0.93

-0.00

1.4

1.6

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.86

-0.00

2.0

2.9

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.93

-0.00

1.8

1.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.00

-0.00

1.0

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

0.92

-0.00

1.2

1.3

62.83

68.29

ug/l

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.3

—

58.73

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.95

-0.00

1.3

62.56

69.97

ug/l

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

6.9

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

-0.00

0.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.8

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: H7_OPTNERVE – Disorders of optic nerve and visual pathways

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Disorders of optic nerve and visual pathways

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Disorders of optic nerve and visual pathways (H7_OPTNERVE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints